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of 0.6 mg/mL EMS, 2 mM NMDA, 200 nM amsacrine, 100 µM chloroquine, 
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test, p > 0.05). US conditions: pressure amplitude of 0.78 MPa, total treatment 
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Figure 7.21: Drug treatment with 0.6 mg/mL EMS and 100 µM chloroquine increased the 
transfection efficiency mediated by US without affecting the cell viability. 
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transfection efficiency mediated by US but decreased the cell viability. Data 
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Figure 7.23: Drug treatment with 2 mM NMDA and 100 µM chloroquine increased the 
transfection efficiency mediated by US but decreased the cell viability. Data 
represent the averages of n ≥ 3 replicates with standard deviation (*paired 
Student’s t-test, p < 0.05). US conditions: pressure amplitude of 0.78 MPa, 
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Figure 7.24: The fold changes of gene transfection efficiency in (a) live cells and (b) all 
cells with drug treatment compared to that without drug treatment. Data 
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 Ultrasound (US) is of interest among the current gene delivery systems due to its 
unique expected advantages, including: low toxicity, low immunogenicity, the potential 
for repeated application, organ specificity and broad applicability to acoustically 
accessible organs. Various US conditions have been tested for gene transfection among 
different types of cell in vitro (Liang et al. 2004; Michel et al. 2004; Zarnitsyn and 
Prausnitz 2004; Larina et al. 2005; Duvshani-Eshet et al. 2006; Fischer et al. 2006; 
Rahim et al. 2006), and with various organs and tissues in vivo, including skeletal muscle 
(Christiansen et al. 2003; Li et al. 2003; Pislaru et al. 2003; Wang et al. 2005), brain 
(Sheikov et al. 2004; Shimamura et al. 2004; Manome et al. 2005), heart (Bekeredjian et 
al. 2003; Guo et al. 2004; Tsunoda et al. 2005), liver (Miao et al. 2005) and kidney 
(Azuma et al. 2003; Lan et al. 2003; Koike et al. 2005; Ng et al. 2005). However, one 
problem in US-mediated gene transfection is the heterogenic bioeffects and thereby the 
low transfection efficiency.  
 In this work, we used megahertz pulsed ultrasound and studied gene transfection 
with a human prostate cancer cell line. We first studied the compromise of cell viability 
and uptake efficiency and found out that increasing sonication temperature or changing 
US contrast agents could improve drug/gene delivery mediated by US exposure. We also 
found that accounting for cell debris after sonication was important to correctly determine 
cell viability. 
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 Next, we verified the capability of US to deliver DNA into the cell nuclei, which 
is necessary for successful gene transfection. Under the optimal sonication conditions, ~ 
30% of cells showed DNA uptake right after US exposure and most had a portion of 
DNA already localized in the cell nuclei. The maximum transfection efficiency was ~ 12% 
at 8 h post US exposure. From the DNA perspective, ~ 30% of DNA was localized in the 
cell nuclei immediately after US exposure and ~ 30% was in the autophagosomes/ 
autophagolysosomes with the rest “free” in the cytoplasm. At later time up to 24 h, DNA 
continued to be distributed ~ 30% in the nuclei and most or all of the rest in 
autophagosomes/autophagolysosomes. Our results showed that US was able to deliver 
DNA into the cell nuclei shortly after the treatment and that the rest of DNA was mostly 
cleared by autophagosomes/autophagolysosomes. 
 To further increase transfection efficiency, we then studied the differences 
between live cells with DNA uptake and those with successful gene transfection post US 
exposure using cell sorting, cell cycle and microarray analysis. Cells with gene 
transfection were found to accumulate at the G1 phase of cell cycle and associate with the 
up-regulation of 32 genes (e.g., GADD45α) and the down-regulation of 46 genes (e.g., 
TOP2α). Drugs that regulate the expression levels of GADD45α and TOP2α were found 
to further enhance the transfection mediated by US. A maximun increase of ~ 2 fold in 
transfection efficiency was observed when cells were sonicated with 0.6 mg/mL ethyl 
methanesulfonate to up-regulate GADD45α. These results suggestted that using drugs 
that regulate certain introcellular processes could further enhance US-mediated gene 
transfection.  
 xxx 
 Over a broad range of US conditions, the integrity of three common gene delivery 
vectors, plasmid DNA, siRNA and adeno-associated virus, were not affected by US 
exposure. This thesis verified that US was able to delivery DNA into the cell nuclei to 
facilitate rapid gene transfection, and provided a proof of princible that by modulating 
certain intracellular processes, the efficiency of US-mediated gene transfection could be 




CHAPTER 1: INTRODUCTION 
 
 Gene therapy is promising as an effective way to treat many genetic disease, but 
limited by the lack of a safe and efficient gene delivery system. Ultrasound (US) has been 
explored as a physical gene delivery method ever since 1987, when Fechheimer reported 
US-mediated gene transfection in mammalian cells for the first time (Fechheimer et al. 
1987). Various US conditions have been tested for gene transfection among different 
types of cell in vitro and organs and tissues in vivo (Azuma et al. 2003; Bekeredjian et al. 
2003; Christiansen et al. 2003; Lan et al. 2003; Pislaru et al. 2003; Guo et al. 2004; Liang 
et al. 2004; Michel et al. 2004; Sheikov et al. 2004; Koike et al. 2005; Larina et al. 2005; 
Manome et al. 2005; Tsunoda et al. 2005; Fischer et al. 2006; Rahim et al. 2006). 
Compared to other methods (e.g., electroporation and chemical gene delivery vectors), 
US is a promising tool for gene therapy because of its unique advantages in safety, 
targeting and specificity. However, there are still many things that are not well 
understood and thereby prevent US from its clinical applications in gene therapy. For 
instance, the cavitation mechanism is not fully clear; the trafficking of exogenous gene in 
the cell cytoplasm is not well understood; how to effectively protect DNA from 
degradation and improve the nuclear import is under investigation. And most importantly, 
heterogeneous bioeffects were found in nearly all the studies using US for gene delivery, 
which is possibly the major reason of the low transfection efficiency.  
 Gene transfection requires overcoming several barriers: cell membrane, 
trafficking in the cytoplasm, nuclear entry, transcription and translation. To overcome 
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these barriers and enhance US-mediated gene transfection, many previous studies have 
focused on the optimization of physical parameters for US conditions, including acoustic 
pressure and energy, treatment time, US contrast agents and so on. Fewer studies looked 
into the biological regulation of intracellular processes such as facilitating the DNA 
trafficking and nuclear entry, and the regulation of gene expression, which could possibly 
be important to achieve high transfection rate. In this work, we hope to have a better 
understanding of the heterogeneous bioeffects caused by US exposure, including DNA 
uptake, gene expression, DNA localization in cell nuclei and cytoplasm. We expected to 
find the certain intracellular processes by regulating which US-mediated gene 
transfection can be further enhanced. We used megahertz pulsed ultrasound and studied 
gene transfection with a human prostate cancer cell line. We were particularly interested 
in:  
 the compromise of cell viability and uptake/transfection efficiency post US 
exposure under optimal US conditions;  
 the qualitative and quantitative analysis of the localization of plasmid DNA in the 
cell nuclei and cytoplasm; 
 the differences between cells that have different bioeffects of DNA uptake or gene 
transfection post US exposure; 
 the possibility to further enhance US-mediated gene transfection by regulating 
some intracellular processes with drug treatment. 
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 This thesis seeks to characterize these processes associated with US-mediated 




CHAPTER 2: BACKGROUND 
 
 Gene therapy is defined as the transfer of new genetic materials (DNA or RNA) 
into cells or targeted tissues for therapeutic benefits. It is proposed to be an effective way 
to treat genetic disease, such as monogenic disorders, cardiovascular disease and cancer 
(Miller 1992; Mulligan 1993; Crystal 1995). The major impediment to the successful 
application of gene therapy is not a paucity of therapeutic genes, but the lack of a safe, 
non-toxic and efficient gene delivery system (Young et al. 2006).  
 The therapeutic applications of ultrasound (US) have been studied and used ever 
since 1930s. The ability of US to transiently permeabilize cell membranes was 
investigated intensively to facilitate drug/gene delivery. Various US apparatus systems 
were designed and a variety of US exposure conditions (e.g., energy intensity, pulse 
length, acoustic pressure) were tested on different types of cells and tissues both in vitro 
and in vivo. The development in US contrast agents further enhanced drug/gene delivery 
using therapeutic US. Compared to other gene delivery systems, this approach is 
promising in clinics, because it is non-invasive, site-specific and easy to perform. US can 
be applied to both surface and deep tissues, both small and large tissues.  
 The low transfection efficiency is currently the major impediment to the clinical 
application of US-mediated gene transfection. US generates strong heterogeneous 
bioeffects and the transfection efficiency is strongly related to cytotoxicity, meaning that 
the compromise between cell viability and transfection efficiency is quite sensitive. 
Furthermore, the bioeffects caused by US exposure differs between the various types of 
cells and tissues. More research work is needed to fully understand the mechanisms of 
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US-mediated gene transfection. And based on those findings, better US delivery systems 
can be designed to achieve higher transfection efficiency.  
Current Gene Delivery Strategies 
 An ideal gene delivery system should have these following characteristics:  
 safety,  
 resistance to metabolic degradation and/or attack by the immune system,  
 specificity for the target cells or tissues,  
 ability to express the therapeutic gene in a time period long enough.  
 Current gene delivery systems are generally classified as two categories: viral and 
non-viral methods. 
Viral Gene Delivery System 
 Viral vectors are the most commonly used gene therapy method because of their 
nature to transfer DNA into cells. Currently a variety of virus vectors have been 
developed for gene delivery. Some of them like adenovirus and vaccinia virus can 
provide transient gene transduction, and others like retrovirus and adeno-associated virus 
can provide permanent transgene expression. Virus vectors can be easily manipulated 
according to the therapeutic genes and cell types, and provide high efficiency and 
possibility of long-term gene expression. They have been used in 70% of gene therapy 
clinical trials (Young et al. 2006). However, the introduction of foreign proteins may 
cause some unknown reactions that may be dangerous to patients. The acute immune 
response, immunogenicity, and insertion mutagenesis uncovered in gene therapy clinical 
trials have raised serious safety concerns about some commonly used viral vectors. 
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Several accidents associated with virus gene therapy have already been reported, 
including fatal accidents (Marshall 1999; Check 2002; Check 2003). Thus safety is a key 
problem when viral vectors are used in gene therapy. The maximum size of the transgene 
that recombinant viruses can carry is another potential limitation of viral gene delivery 
systems. 
Non-viral Gene Delivery Systems 
 Non-viral gene delivery systems have been explored using chemical and physical 
approaches. These delivery systems are generally less efficient than viral vectors, 
especially in vivo. However, in contrast to viral delivery systems, DNA can be delivered 
without carrier proteins and therefore is typically non-immunogenic. 
 Chemical approaches (Nicolazzi et al. 2003; Dass 2004; Neu et al. 2005) use 
synthetic or naturally occurring compounds as carriers to deliver the DNA into cells. The 
therapeutic genes are usually immobilized, adsorbed, attached, or encapsulated into the 
chemical formulations, which are cationic lipid-based (lipoplexes) or cationic polymer-
based (polyplexes) or lipid-polymer hybrid system. The DNA-containing particles are 
subsequently taken up by cells via endocytosis, macropinocytosis, or phagocytosis in the 
form of intracellular vesicles, and a small fraction of the DNA is released into the 
cytoplasm and migrates into the nucleus, where transgene expression takes place. Studies 
have been conducted to improve DNA uptake by cells and intracellular trafficking to the 
nucleus. Although these chemical approaches seem effective for in vitro gene delivery, 
they are not impressive in clinical trials due to the low transfection efficiency or toxicity 
because of the non-biodegradable nature of some gene carriers. And how to control the 
spatial delivery to the desired tissue is also a big challenge. 
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 Gene delivery using chemical approaches involve such procedures as cell 
attachment, endocytosis and entrapment into endocytic vesicles, maturation of 
endosomes into lysosomes, escape from vesicular compartments, migration toward the 
nucleus periphery, dissociation between carriers and foreign DNA, and finally entry of 
DNA into the nucleus. In contrast, physical methods can bypass some of the above 
barriers. Physical approaches provide carrier-free gene delivery by employing a physical 
force that permeates the cell membrane and facilitates intracellular gene transfer. These 
systems include microinjection (King 2004), magnetofection (Scherer et al. 2002; Plank 
et al. 2003), laser irradiation, gene gun (Yang et al. 1990), hydrodynamic delivery (Zhang 
et al. 1999), electroporation (Andre and Mir 2004; Heller et al. 2005) and ultrasound 
(Newman and Bettinger 2007).  
Microinjection  
 Microinjection is the direct-pressure injection of a solution into a cell through a 
glass capillary. It is an effective and reproducible method for introducing DNA into cells, 
and DNA can be delivered directly to the nucleus. However, microinjection is applied to 
cells one by one and therefore transfection is limited by the number of cells that can be 
treated. Currently this approach is the most common method for the production of 
transgenic animals (Uchida et al. 2001; Auerbach 2004; Hofmann et al. 2004). 
Magnetofection  
 Magnetofection exploits paramagnetic particles made of iron oxide as drug 
carriers, guides their accumulation in target tissues with local strong magnetic fields. This 
method causes rapid sedimentation of nearly all gene delivery vectors on the target cells 
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and DNA uptake via endocytosis. It is also combined with chemical methods to develop 
gene carriers. More investigations need to be conducted. For example, changes in cellular 
physiology upon exposure to the magnetic field are not known yet (Plank et al. 2003). 
Laser Irradiation  
 Laser irradiation requires a laser source to generate the laser beam, which focuses 
on the target cell and permeabilizes the cell membrane by a local thermal effect. There 
are reports showing that laser irradiation can also create transient pores on the cell 
membrane, which allow gene uptake (Kurata et al. 1986; Shirahata et al. 2001). The 
approach is not widely used mainly due to the high cost and physical size of the laser 
sources. The transfection efficiency depends on parameters like the pulse length and 
number, and total energy level. 
Gene Gun  
 Gene gun was first used in plant cells in 1987 (Klein et al. 1987), and was applied 
to mammalian cells in the early 1990s (Yang et al. 1990). Gene gun deposits DNA on the 
surface of gold particles and accelerates the particles by pressurized gas. The particles 
penetrate into cells or tissues and release DNA for transfection. This method is also 
called particle bombardment and it may be good for DNA immunization to skin or 
exposed tissue (Eisenbraun et al. 1993; Wang et al. 2004). The depth of penetration is a 
big limitation and the device and gold particles are expensive.  There are currently two 
major devices commercially available: Accell gene gun (Agracetus, Inc., Middleton, WI) 
and the Helios gene gun (BioRad Laboratories, Hercules, CA). 
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Hydrodynamic Delivery  
 Hydrodynamic gene delivery has been studied in the mouse model in vivo. The 
rapid tail vein injection of a large volume of DNA solution causes a transient overflow of 
injected solution at the inferior vena cava and induces a flow of DNA solution in 
retrograde into the liver. And thus a rapid rise of intrahepatic pressure, liver expansion, 
and reversible disruption of the liver fenestrae allow DNA to enter the hepatocytes (Liu et 
al. 2004; Zhang et al. 2004). The transfection efficiency depends on the structure of the 
organ and the volume and speed of injection. A big limitation of this method is that it is 
only applied to certain highly perfused organs like liver. And it is currently not applicable 
to inject large volume of solution in humans. 
Electroporation  
 Electroporation is a common physical tool in gene delivery to cells. This approach 
applies electrical pulses to cells and creates a transient permeability of cell membranes 
which allows the entry of foreign DNA. Different electrode configurations and a wide 
range of pulse patterns have been developed depending on the cells or tissues to be 
treated. Electroporation has proved to be effective both in vitro and in vivo, including in 
various tissues like skin, liver, lung, kidney, bladder, retina, cornea, brain, skeletal muscle 
and so on (Wells 2010). Transfection efficiency mediated by electroporation is influenced 
by several physical (especially, pulse duration and electric field strength) and biological 
(including DNA concentration and conformation, cell size) factors.  
 Several major drawbacks exist for in vivo application of electroporation. Firstly, 
an invasive procedure is required to place the electrodes deep into the internal organs. 
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Secondly, it has a limited effective range (approximately 1 cm) between electrodes, 
which makes it difficult to transfect cells in a large area of tissue. Thirdly, electroporation 
for a cell suspension requires a voltage up to 1 kV (Gehl 2003). The high voltage applied 
to cells could affect the stability of genomic DNA, which is an additional safety concern. 
More investigations need to be conducted to address these concerns, maybe by 
optimizing the design of electrodes, their spatial arrangement, the field strength, and the 
duration and frequency of electric pulses. 
Ultrasound 
 US-generated cavitation creates a transient permeability of cell membrane which 
allows the entry of DNA, like electroporation. US with US contrast agents has been 
studies as a promising method for gene therapy. US can penetrate tissues with the 
minimum damage and focus its energy to non-superficial objects within a small volume. 
These properties lead to non-invasive and site-specific gene delivery. The efficiency of 
US-mediated gene transfection is also influenced by physical (acoustic pressure, pulse 
length and exposure duration) and biological (including DNA concentration, cell 
concentration and size) factors. So far, the major problem for US-facilitated gene delivery 
is low gene transfection efficiency. 
 
Ultrasound, Cavitation and Ultrasound Contrast Agents 
Ultrasound 
 US is sound pressure with a frequency greater than the upper limit of human 
hearing, which is approximately 20 kHz. Therefore, US is classified as sound pressure at 
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frequencies above 20 kHz (Figure 2.1). US is widely used in clinics (e.g., imaging, 
cleaning, etc) and industries (e.g., welding).  
 
 
Figure 2.1: The frequencies of infrasound, acoustic sound and ultrasound. 
 
 Ultrasound is generated by a transducer which is usually made from piezoelectric 
materials like quartz or lead zirconate titanate (Asher 1997). A suitable alternating 
voltage is applied to the transducer. When the frequency of the input voltage reaches the 
resonance frequency for the vibration of the transducer, the piezoelectric material 
responds by undergoing vibrations. These vibrations are transmitted to the environment 
through a certain medium (e.g., water) as a periodic pressure wave (Pierce 1981). 
Cavitation 
 Acoustic cavitation refers to the dynamical response of bubbles driven by acoustic 
pressure. When periodic positive and negative pressures generated by US produce a 
density gradient in the solution, the negative pressure could overcome a tension 
maintaining the liquid state, thereby generating a “cavity” in the solution. This is called 
cavitation. In the position of the cavity, microbubbles are produced. Two common 
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saturation with gas, or bubbles that form when the local pressure of the liquid decreases 
to below the vapor pressure of the liquid or decreases to such a low pressure that 
dissolved gas comes out of the solution.  
 Acoustic cavitation activity is classified as two categories: stable cavitation and 
transient cavitation (inertial cavitation). Stable cavitation refers to the repetitive pulsation 
of an acoustically driven bubble at an equilibrium radius. The bubbles vibrate in reaction 
to the pressure but undergo no change in size. Stable cavitation enhances the convective 
transport occurring within the liquid because the vibrating surface creates local swirling 
fluid convection, known as micro-streaming (Miller 1987). If the vibrating microbubbles 
expand during several cycles of growth under pressure and finally collapse, it is called 
transient cavitation. The collapse of bubbles is quite violent and is dominated by the 
inertia of the inrushing fluid. The physical effects of inertial cavitation include micro-
streaming, fluid jetting, extreme thermodynamic conditions in the microbubble leading to 
light production (sonoluminescence) and chemical reactions (sonochemistry) (Leighton 
1994). It is also noticed that the acoustic effects are associated with the frequencies and 
intensities of US (Carstensen et al. 1980; Muir and Carstensen 1980). For a given size of 
a microbubble, the intensity threshold to trigger inertial cavitation decreases as the US 
frequency decreases (Urick 1983). Low frequency US (< 1 MHz) causes strong 
cavitation, while higher frequency US causes more thermal energy deposition. 
US Contrast Agent 
 US contrast agents are “soft-shelled” agents made of gas microbubbles. They 
have a gas core surrounded by a shell made from various materials, for example, 
polymer, lipid and protein. US contrast agents can serve as cavitation nuclei and enhance 
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the physical effects of US. Currently there are many commercially available US contrast 






 and so on. Table 2.1 briefly 









 have been approved by FDA. 
 
 Table 2.1: Physicochemical characteristics of US contrast agents. 
 
 Besides the above soft-shelled US contrast agents, hard-shelled contrast agents 
(containing a rigid lipid or polymeric shell) have also be developed. These agents, 
although not currently commercially available, have been studied for diagnostic imaging 
(Schneider et al. 1991), drug delivery (Frinking et al. 1998), acoustic properties (Frinking 
and de Jong 1998; Hoff et al. 2000), and other biophysical applications (Bouakaz et al. 
1999). Future studies in drug delivery are to develop US contrast agents with multiple 
functions, not only cavitation nuclei, but also drug carriers and tissue targeting for 
specific drug delivery purpose (Bekeredjian et al. 2006; Lum et al. 2006). For instance, 
US Contrast 
Agent Shell Encapsulated Gas 
Bubble Size  
Mean (Range)  
Sonazoid Surfactant Fluorocarbon 3.2 μm (1 – 10 μm) 
Levovist Galactose/palmitic acid  Air 2 – 3 μm (2 – 8 μm) 
Optison Albumin Octafluoropropane 4.7 μm (1 – 10 μm) 
SonoVue Phospholipid  Sulphur hexafluoride 2.5 μm (1 – 10 μm) 
Definity Phospholipid Perfluoropropane 1.5 μm (1 – 10 μm) 
Albunex Albumin Air 4.5 μm (1 – 10 μm) 
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microbubbles can be prepared to encapsulate generic materials and to contain ligands like 
antibodies or specific peptides, which would bind to the specific target cells or tissues 
and therefore cause a close contact between microbubbles and the target of treatment 
(Feril 2009). 
 
Ultrasound in Biomedical Applications 
US is now broadly used in biomedical applications as a therapeutic, diagnostic or 
surgical instrument. The energy intensities for its therapeutic application generally range 
from 0.5 to 3 W/cm
2
. Diagnostic US uses lower intensities (< 0.5 W/cm
2
) and surgical 
US uses higher intensities (> 10 W/cm
2
) (Ng and Liu 2002). 
Therapeutic Applications 
US was first introduced as a therapeutic method in 1930s, when the heating 
effects of US were applied to inner tissue for physical therapy. Ever since then, a variety 
of therapeutic US applications has been reported, for instance, rapid and localized tissue 
heating (Kennedy 2005; Haar and Coussios 2007), mechanical tissue damage and 
homogenization (Roberts et al. 2006), dissolution of blood clots (thrombolysis) 
(Everbach and Francis 2000; Datta et al. 2006), vascular occlusion (acoustic hemostasis) 
(Vaezy and Zderic 2007), locally enhanced and time-released activity of drugs 
(sonodymanic therapy) (Kinoshita and Hynynen 2006), reversible permeability to large 
molecules for drug delivery (sonoporation) (Mitragotri 2005), reversible opening of the 
blood-brain barrier (Mesiwala et al. 2002; Hynynen et al. 2005) and so on. 
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Diagnostic Applications 
US has been used by radiologists and sonographers to image the human body for 
at least 50 years and has become one of the most widely used diagnostic tools in modern 
medicine without any known adverse “side effects”. US-based diagnostic medical 
imaging techniques are used to visualize muscles, tendons, and many internal organs, to 
capture their size and structure. Diagnostic US is also used to visualize fetuses during 
routine and emergency prenatal care (so-called obstetric sonography), to confirm fetal 
viability, check for fetal movement and heartbeat, and determine the sex of the baby 
(Whitworth et al. 2010).  
Surgical Applications 
US surgery was first proposed as a tool of neurosurgical research in 1940s (Lynn 
et al. 1942). High intensity of US (> 10 W/cm
2
) can be focused at a distance within the 
body and produce selective damage within the focal volume with no harm to the 
surrounding tissues. This technique has clear advantages over traditional forms of 
surgeries in clinics. Some examples are using US to kill tumor cells or break up kidney 
and gall bladder stones (lithotripsy) (Terhorst et al. 1972; Toth et al. 1988; Callans and 
Gadacz 1990; Mink et al. 1991; el Khader et al. 1995; Guo 1995; Yoshizawa et al. 2009; 
Gu et al. 2010).  
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Ultrasound-mediated Gene Transfection 
 US-mediated gene transfection is of interest due to its unique expected 
advantages, including: low toxicity, low immunogenicity, the potential for repeated 
application, organ specificity and broad applicability to acoustically accessible organs 
(Gao et al. 2007). However, it is in the early stage of clinical implementation with the 
major challenge of low transfection efficiency. 
Current Research on US-mediated Gene Transfection 
Ever since Fechheimer and his colleagues reported US-mediated gene transfection 
on mammalian cells in 1987 (Fechheimer et al. 1987), many groups have contributed to 
the study of gene transfection mediated by US with different types of cells in vitro (Liang 
et al. 2004; Michel et al. 2004; Zarnitsyn and Prausnitz 2004; Larina et al. 2005; 
Duvshani-Eshet et al. 2006; Fischer et al. 2006; Rahim et al. 2006), and with various 
organs and tissues in vivo, including skeletal muscle (Christiansen et al. 2003; Li et al. 
2003; Pislaru et al. 2003; Wang et al. 2005), brain (Sheikov et al. 2004; Shimamura et al. 
2004; Manome et al. 2005), heart (Bekeredjian et al. 2003; Guo et al. 2004; Tsunoda et 
al. 2005), liver (Miao et al. 2005) and kidney (Azuma et al. 2003; Lan et al. 2003; Koike 
et al. 2005; Ng et al. 2005). Besides reporter genes (e.g., plasmids encoding green 
fluorescent protein, β-galactosidase and luciferase), transfection with “therapeutic” genes 
using US exposure was also investigated (Kondo et al. 2004; Akowuah et al. 2005; Miao 
et al. 2005; Sakakima et al. 2005). 
The development of stabilized microbubbles for increasing sensitivity and 
applicability further strengthened US as a powerful and safe tool for future gene delivery 
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(Bekeredjian et al. 2006). However, the US-mediated transfection efficiency is still 
comparatively low. The efficiency of gene transfection using liposomes can reach above 
50% (Yamamoto et al. 1999), while US-mediated gene transfection only gives around 
10% efficiency and fewer studies have shown transfection efficiency above 30% (Nozaki 
et al. 2006). Although a lot of work has been done to optimize the US parameters (e.g. 
pressure, exposure duration, energy intensity) and sonication conditions (e.g. cell 
concentration, US contrast agent concentration and plasmid concentration), low 
transfection efficiency is still the major challenge in US-mediated gene transfection. And 
transfection efficiency varies with different US contrast agents and different types of cells 
and tissues. 
US exposure was found to generate heterogeneous bioeffects, which may be one 
of the major reasons of the low transfection efficiency. US opens the cell membrane so as 
to allow drug/gene entry, which is desired, but at the same time it puts cells in risk, which 
is unwanted. Cells close to the location of cavitation are likely destroyed by US exposure, 
cells at mid-distances from the microbubbles exhibit drug/DNA uptake with the cell 
membrane temporarily opened and rapidly resealed, and cells far from the cavitation 
microbubbles remain unaffected. Therefore, higher molecule uptake may be achieved 
under strong US conditions, but associated with higher cell death rate. To maintain a low 
death rate under gentle exposure conditions may lead to the uptake efficiency not high 
enough for applicable drug delivery. The compromise between high viability and high 
uptake efficiency is quite challenging. It is also worth noting that individual cells exposed 
in vitro may be more sensitive to US exposure than the tightly packed cells in tissues. 
Under similar US conditions which cause a lot of cell death in vitro may lead to 
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successful drug/gene delivery without much tissue damage in vivo (Danialou et al. 2002; 
Li et al. 2003). 
Although cavitation is believed to play a major role in the cell membrane 
permeabilization (Miller et al. 1996; Kimmel 2006), the mechanisms by which US 
mediates gene transfection is not fully clear, particularly whether US affects later steps in 
gene transfection pathways, which are possibly the rate-limiting steps (e.g., DNA 
trafficking in the cytoplasm and entry into the nucleus). Along with the bioeffects of drug 
delivery and gene transfection, US was found to induce intracellular bioeffects as well. 
Changes in cell behavior after US exposure were reported, including morphology 
(Schlicher et al. 2010), proliferation (Bao et al. 1997; Lawrie et al. 1999), apoptosis 
(Ashush et al. 2000), migration and adhesion (Alter et al. 1998). Currently, limited 
expression profiling data provided by microarray analysis revealed that US regulated 
ribosomal proteins expression, influenced cell proliferation and differentiation, induced 
cell cycle arrest and apoptosis (Abdollahi et al. 2004; Tabuchi et al. 2007). These 
intracellular bioeffects may be cell-type specific and US-condition dependent. Whether 
these changes in intracellular processes are related to US-mediated gene transfection 
remains a question. 
Research in US-mediated gene transfection still has a long way to go, with the 
major challenge of low transfection efficiency. More studies on the heterogeneous 
bioeffects, unclear mechanisms and unknown cellular pathways influenced by US 
exposure will possibly explain the reasons of low efficiency and further enhance gene 
transfection (Paliwal and Mitragotri 2006; Campbell and Prausnitz 2007). 
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Mechanisms of US-mediated Gene Transfection 
 Successful gene transfection requires both extracellular and intracellular barriers 
to be overcome. These barriers include plasma membrane, which is the barrier of DNA 
uptake, the cytoskeletal meshwork in the cytoplasm, which hinders DNA trafficking in 
the cytoplasm, and the nuclear envelope, which prevents DNA entry into the nucleus. The 
gene delivery system has to send the exogenous DNA to the nucleus before any 
transcription can take place. Although the mechanisms of US-mediated gene transfection 
are still under investigation and discussion, some theories and hypotheses have been 
proposed to explain how naked plasmid DNA comes into cells across the cell membrane, 
traverses in the cytoplasm, arrives inside the nucleus and gets ready for transcription and 
translation. 
Plasmid DNA Uptake  
 Unlike chemical delivery systems, US-mediated DNA uptake is non-endocytotic, 
which allows a rapid and direct transfer of exogenous DNA into the cytoplasm. 
Cavitation is considered as one of the mechanisms of molecule uptake mediated by US. 
In transient cavitation, microbubbles collapse causes a sudden release of energy and in 
turn leads to a series of thermal, chemical and mechanical effects locally. The mechanical 
stress is thought to generate transient pores on the cell membrane close to the 
microbubbles, which allow an influx of external molecules into the cell (Schlicher et al. 
2006). Strong correlation of cavitation caused by US with cellular uptake mediated by US 
has been demonstrated (Hallow et al. 2006). Some research found that the poration of the 
cell membrane could last from milliseconds (van Wamel et al. 2004) to nearly 24 h 
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(Taniyama et al. 2002), but efficient drug/gene delivery can be achieved within seconds 
(Schlicher et al. 2006). 
 The cavitation mechanism leads to the heterogeneous bioeffects of US exposure. 
Cells proximal to the cavitating microbubbles are mechanically destroyed, cells at mid-
distances from the microbubbles exhibit reversible poration and drug/DNA uptake, and 
cells far from the microbubbles remain unaffected (Guzman et al. 2001; Schlicher et al. 
2006). How to predict and control these heterogeneous bioeffects based on the 
understanding and measurement of the cavitation is under investigation. 
 Plasmid DNA Trafficking in Cytoplasm 
 DNA uptake is only the first step for gene transfection. After the plasmid DNA 
enters the cell successfully, it has to traverse the cytoplasm and enter the nucleus prior to 
transcription and translation. This process needs to be quick since nucleases in the 
cytoplasm start to degrade exogenous DNA in minutes (Lechardeur et al. 1999; Pollard et 
al. 2001).  
 The fluid-phase viscosity of the cytoplasm is in the range from 1.1 to 1.4 cP 
(Fushimi and Verkman 1991; Luby-Phelps et al. 1993), which is only slightly greater 
than water. However, the multiple cytoskeletal elements (e.g., microfilaments, 
microtubules and intermediated filaments) in cytoplasm form a complex and crowded 
latticework that significantly impedes the diffusion of large molecules. The passive 
diffusion of plasmid DNA in the cytoplasm is generally very slow, especially for DNA 
molecules lager than 1000 base pair (660 kDa). In fact, very few DNA molecules were 
found to be able to move away from the original site 1 h after microinjection into the 
cytoplasm (Lukacs et al. 2000). It has been shown in non-viral gene transfection that a 
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certain amount of plasmid DNA stays in the cytoplasm after entering the cell, which is 
considered as one of the reasons for low transfection efficiency by non-viral gene 
delivery methods.  
 Cytoskeleton regulates intracellular transport by impeding the passive diffusion of 
large molecules and providing active transport. One of the bioeffects mediated by US 
exposure is the alteration of cytoskeleton (Skorpikova et al. 2001; Raz et al. 2005), which 
may help in the passive diffusion of exogenous DNA by reducing crosslinks and actin 
fibers. And also, unlike chemical gene delivery systems, where gene vectors were found 
entrapped in large endocytic vesicles formed at the cell membrane, plasmid DNA was 
distributed throughout the cytoplasm right after US exposure (Zarnitsyn and Prausnitz 
2004; Mehier-Humbert et al. 2005b; Duvshani-Eshet et al. 2006). Because of the above 
two possible reasons, naked exogenous DNA may be propelled into perinuclear region 
for nuclear import right after US exposure. Therefore the kinetics of plasmid 
internalization and gene expression was found faster in US-mediated gene transfection 
compared to chemical methods (Mehier-Humbert et al. 2005b). 
 Microtubule network is responsible for intracellular transport of cargos from the 
cell membrane to the nucleus. Dynein is one of the adaptor proteins associated with this 
process. Many viruses and endocytosed materials including some chemical gene delivery 
vectors are verified to utilize microtubules to reach the nucleus (Bukrinskaya et al. 1998; 
Suomalainen et al. 1999; Vihinen-Ranta et al. 2000; Ogawa-Goto et al. 2003; Bausinger 
et al. 2006). It is suggested that plasmid DNA may also utilize microtubules to transport 
from the cell membrane to the nucleus in other physical gene delivery systems, such as 
electroporation and microinjection (Vaughan and Dean 2006). However, it is believed 
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that intermediate adapter proteins may be required, since DNA cannot bind to the motor 
proteins directly. Besides microtubule, baculovirus and HIV virus were also found to use 
actin cytoskeletal network to traffic its genome toward the nucleus (van Loo et al. 2001; 
McDonald et al. 2002). 
DNA Nuclear Import 
 Another barrier to gene transfection is the nuclear envelope, which separates the 
nucleus from the cytoplasm. The level of gene expression after delivery is limited by low 
quantities of exogenous DNA available for nuclear import (Brisson et al. 1999; 
Subramanian et al. 1999). Transport of molecules into the nucleus occurs through nuclear 
pores. Molecules with a diameter less than 10 nm or a molecular weight less than 70 kDa 
are able to diffuse passively through the nuclear pore (Melchior and Gerace 1995). Larger 
molecules including protein, DNA and RNA need to be transported actively by nuclear 
transport receptors through an energy-dependent process (Conti and Izaurralde 2001). It 
has been shown that the nuclear envelop is not a major hindrance to gene transfection in 
actively-dividing cells compared to non-dividing cells, where the nuclear envelope 
remains intact (Fasbender et al. 1997). Using chemical gene delivery methods, cells 
undergoing mitosis were found to be more ready for transfection (Wilke et al. 1996; 
Tseng et al. 1999), which suggests that nuclear envelope temporarily breaks down during 
mitosis therefore facilitates transfection and gene transfection efficiency may be 
dependent on the stage of cell cycle (Brunner et al. 2000). Synthetic nuclear localization 
signal (NLS) peptides can be recognized by nuclear pores and have been developed to 
bind to DNA and facilitate DNA delivery into the nucleus (Cartier and Reszka 2002). 
Nuclear import of plasmid DNA in non-dividing cells was also found to be DNA 
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sequence-specific and several DNA nuclear targeting sequences (DTS) were designed as 
an enhancer to help nuclear import in several cell lines (Graessmann et al. 1989; Dean 
1997; Langle-Rouault et al. 1998). 
Regulation of Intracellular Processes by US Exposure 
 It has been shown that a variety of cells behave differently under stress, including 
both chemical and mechanical stress (Ingber 2002). Signaling cascades, intracellular 
processes and transcription factors may be either up-regulated or down-regulated, and 
cytoskeleton may be reorganized as well. Under extreme stress, cells may even enter 
apoptosis. Similarly, cells may also undergo certain unknown intracellular processes 
regulation under the stress due to US exposure. Microarray and gene technology have 
been applied to the study of US-mediated regulation of intracellular signaling pathways 
(Tabuchi et al. 2007). Some research work has shown US-mediated regulation of 
ribosomal proteins (Abdollahi et al. 2004). The change in the ratio of ribosomes to 
mRNA can in turn affect protein synthesis. There are also reported results that US 
exposure activates DNA synthesis and promotes cell proliferation by activation of a 
Rho/Rock/ERK signaling pathway (Zhou et al. 2004). In brief, US may enhance gene 
transfection efficiency by regulating intracellular processes, and vice versa, facilitating 
these intracellular processes may also help in US-mediated gene transfection. 
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CHAPTER 3: MATERIALS AND METHODS 
 
General Experimental Methods 
Ultrasound Apparatus 
 The US transducer was an immersible, focused, piezoceramic transducer (Sonic 
Concepts, Woodinville, WA, USA, model no. H-101), supplied with two different 
matching resistance networks allowing production of sound at 1.1 MHz and 1 MHz. The 
transducer had a diameter of 70 mm, a 52 mm focal length and a 1.5 mm focal width at 
half-amplitude (-6 dB). A sinewave was provided by two programmable waveform 
generators (Standford Research Instruments, Sunnyvale, CA, USA, model no. DS345 and 
Agilent, Austin, TX, USA, model no. 33120A) and amplified by an RF broadband power 
amplifier (Electronic Navigation Industries, Rochester, NY, USA, model no. 3100LA).  
The transducer was submerged in deionized and partially degassed water at 37 ºC 
placed in a polycarbonate tank (30.5 x 29 x 37 cm) to sonicate a 375 μL sample held 
within a disposable micropipette (Samco, San Fernando, CA). A 5-cm thick acoustic 
absorber (SC-501 Acoustic Rubber, Sonic Concepts) was placed opposite the transducer 
in the tank to minimize standing-wave formation. A three-axis positioning system (10 μm 
resolution, Velmex, Bloomfield, NY, USA) was mounted on top of the tank to position 
samples and a hydrophone at desired locations in the tank.  
The US transducer was calibrated versus the peak-to-peak voltage of the signal by 
a PVDF membrane hydrophone (NTR Systems, Seattle, WA, model no. HMA-0200) at a 
distance of 1 cm from the transducer (Appendix A). Sonication was carried out at 
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pressures (p) ranging from 0 MPa (i.e., “sham” exposure) to 2 MPa and the total 
treatment time (t) up to 60 min with a desired burst length at a desired duty cycle (D). 
Therefore the corresponding energy density (J) was calculated as  
, 
where ρ is the density of water (1 g/mL) and u is the speed of sound in water 
(1,500 m/s).  A typical US condition used for gene transfection study is: 
 Peak-to-peak pressure: 0.78 MPa, 
 Duty cycle: 25%, 
 Pulse length: 0.25 ms, 
 Total treatment time: 1 min. 
Cell Culture 
 DU145 human prostate cancer cells (American Type Culture Collection, 
Manassas, VA, item no. HTB-81) in RPMI-1640 medium (Cellgro, Mediatech, Herndon, 
VA) and human HT-1080 fibrosarcoma cells (American Type Culture Collection, item 
no. CCL-121) in DMEM medium were cultured as monolayers in a humidified 
atmosphere of 95% air and 5% CO2 at 37 ºC. The medium was supplemented with 10% 
heat-inactivated fetal bovine serum (FBS, Atlanta Biologicals, Atlanta, GA) and 1% 
penicillin/streptomycin (Cellgro).   
Cell Samples for US-mediated Gene Transfection 
 DU145 cells were harvested according to the standard procedure (Hallow et al. 
2006) and resuspended in RPMI-1640 medium at the final concentration of 1×10
7
 
cells/mL for US exposure. Cell concentration was determined by Multisizer™ 3 Coulter 
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Counter (Beckman Coulter, Inc. Fullerton, CA). The plasmid DNA (pDNA) encoding 
green fluorescent protein (GFP), gWiz
TM
-GFP (Aldevron, Fargo, ND) was used in 
transfection. The pDNA was added to the cell suspension at a concentration of 20 µg/mL 
for US exposure. 
 Definity
®
 US contrast agent (Bristol-Myers Squibb Medical Imaging, North 
Billerica, MA) was added to cell samples at a concentration up to 2 vol% to serve as 
cavitation nucleation sites.  
General Fluorescent Probes 
Plasmid DNA Labeling 







3 kit and Cy
TM
5 kit (Mirus, Madison, WI) 
were used to label pDNA gWiz
TM
-GFP and gWiz™ High-Expression control vector 
(gWiz™ Blank, Aldevron) before US exposure. The labeling reaction was conducted 
according to the procedure recommended by the manufacturer.  
Nuclear Labeling 
 Hoechst 33342 (trihydrochloride, Invitrogen, Carlsbad, CA) and propidium iodide 
(PI, Invitrogen) were used to stain nuclei separately. Hoechst 33342 was added to cell 
samples at the final concentration of 10 µg/mL for 10 min at room temperature (RT). PI 
was added to sonicated cell samples at a concentration of 1 vol% for 5 min at RT to 





 Green DND-26 (Molecular Probes, Invitrogen) was used to label 
acidic organelles in live cells. The reagent was added to cells in growth medium at a final 
concentration of 50 nM and incubated for 5 min at growth conditions. Cells were then 
washed three times before flow cytometry or microscopy analysis. 
EEA-1 (final dilution rate 1:250, BD Bioscience, San Jose, CA), CD63 (final 
dilution rate 1:10, Developmental Studies Hybridoma Bank, Iowa City, IA) and LAMP-1 
(final dilution rate 1:5, Developmental Studies Hybridoma Bank) were used as the 
primary antibody to label early endosomes, late endosomes and lysosomes, respectively. 
Alexafluor 488 Donkey anti Mouse A-21202 (Invitrogen) was used as the secondary 
antibody at a final concentration of 2 µg/mL. Cells plated on the coverslip (VWR 
International, West Chester, PA) were fixed in 2% formaldehyde for 10 min at RT and 
washed twice with PBS. Cells were treated with 10% serum and 0.02% (w/v) sodium 
azide in PBS for 5 min at RT and washed twice with PBS. Cells were then incubated with 
the primary antibody diluted in PBS with 10% serum and 0.2% saponin for 1 h in 
darkness at RT, and washed twice in PBS with 10% serum. After that, cells was 
incubated with the secondary antibody diluted in PBS with 10% serum and 0.2% saponin 
for 1 h in darkness at RT, and washed twice in PBS with 10% serum. 
Flow Cytometry (FCM) 
 The pDNA uptake, transfection efficiency, cell viability and cell cycle were 
measured by a BD LSR benchtop flow cytometer (BD LSR, Becton Dickinson, San Jose, 
CA), and data were analyzed by FCS Express V3 (De Novo Software, Los Angeles, CA) 
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or FlowJo software (Tree Star, Ashland, OR). Typical analysis sampled approximately 
10,000 cells. Samples were excited with a 488 nm laser to measure GFP expression (GFP 
fluorescence) with a 530/30 nm bandpass filter for emission. A 633 nm laser was used to 
measure pGFP uptake (Cy5 fluorescence) using a 660/20 nm bandpass filter for emission. 
Cell populations were first elucidated by gating (Figure 3.1a), and histogram data were 











Figure 3.1: FCM analysis of cell samples after US exposure. (a) The scatter diagram 
of all the events with intact cells gated. FSC-A: forward scatter A is a parameter 
related to cell size by measuring light scattered less than 10 degrees as a cell passes 
through the laser beam. SSC-A: side scatter A is a parameter related to the internal 
granularity or complexity of a particle by measuring light scattered at a 90 degree 
angle as a cell passes through the laser beam. (b) The histogram of gated cells. 
FITC-A: a parameter indicating the light intensity of FITC.  
 
 The viability of DU145 cells post US-mediated gene transfection was determined 
by comparing the cell concentrations in samples to that in the “sham” exposure controls. 
Briefly, viable cells were counted in each sample, normalized based on the fluid volume 
analyzed by the flow cytometer and then normalized to the viability of a non-sonicated 
control sample. The analysis time of a sample in the flow cytometer was used as a 
measure of the sample volume analyzed, since the flow cytometer operated at a constant 
flow rate. Transfection efficiency and pDNA uptake were measured by determining the 
percentage of cells with the corresponding fluorescence greater than a threshold value 
based on untreated control cells (Figure 3.1b).  
Confocal Microscopy 
 A Zeiss LSM 510 confocal laser-scanning microscope or Zeiss LSM META/NLO 
510 multiphoton microscope (Zeiss, Thornwood, NY) was used to visualize the pDNA 
uptake and GFP expression. The lasers for blue, green and red fluorescence were UV 
(wavelength 364 nm), Argon (wavelength 488 nm) and Helium-neon (wavelength 543 
nm). Images were captured by directing a 60× magnification oil objective or a 40× 
magnification objective. Hoechst 33342 was added to cell samples at the final 
concentration of 10 µg/mL for 10 min at RT. Cell samples were viewed on a 25 mm 
round glass cover slip in an Attofluor Cell Chamber (Molecular Probes, Invitrogen). 
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Image Analysis 
 Zen software (Zeiss) and Volocity 3DM software (Improvision, Lexington, MA) 
were used for 3D image analysis to identify and quantify colocalization.  
Methods for Chapter 4 
Experimental Protocols 
US Procedures 
 DU145 cells at a final concentration of 1×10
6
 cells/mL were mixed with 10 µM 
FITC–labeled dextran (70 kDa, Sigma, St. Louis, MO) and 2 vol% Optison
®
 (GE 
Healthcare, Princeton, NJ) or 0.1 vol% Definity
®
 for US exposure. The temperature for 
US treatment was either RT or 37 ºC. The peak-to-peak pressure was 0.39 MPa, duty 
cycle was 25% and total treatment time was 1 s. Samples were washed with PBS for 
three times after sonication to remove extracellular FITC-dextran and cells were 
resuspended in PBS. 
Bioeffects Analysis 
 PI was added to cell samples at the final concentration of 1 vol% to measure cell 
viability after US exposure. A 488 nm laser was used in FCM for excitation and a 575/20 
nm bandpass filter for emission to determine the number of intact cells lacking red 
fluorescence due to PI staining compared to untreated control cells. These cells were 
counted as intact viable cells. The viability of DU145 cells after US exposure was 
determined by normalizing the number of intact viable cells based on the fluid volume 
analyzed by the flow cytometer and then normalized to the number of intact viable cells 
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of a control sample in the fluid volume. The analysis time of a sample in the flow 
cytometer was used as a measure of the sample volume analyzed, because the flow 
cytometer operated at a constant flow rate. In this way, lysed cells, intact viable and dead 
cells were all taken in consideration. The following is an example. 
 In a “sham” control sample, the number of intact viable cells is N0, and the time 
for FCM analysis is T0. In a sonicated sample, the number of intact viable cells is N1, the 
number of all the intact cells is Ns and the time for FCM analysis is Ts. Therefore, the 
number of intact dead cells is (Ns - N1). The viability of intact cells is N1/Ns (not 
accounting for cell debris generated by US exposure). When cell debris is accounted for, 
the overall viability after US exposure is:  
     
     
 
 The uptake efficiency of intact cells (not accounting for cell debris) after US 
exposure was measured by FCM with a 488 nm laser and a 530/30 nm bandpass filter for 
emission and determined by the percentage of cells showing green fluorescence 
compared to untreated control cells. The overall uptake efficiency is the uptake efficiency 
of intact cells multiplied by the overall viability. 
The Analysis of Data from Literature 
 Cell viability and uptake efficiency data from various studies using a variety of 
cell types and tissues, different size of molecules and US apparatus and conditions were 
read and replotted as uptake efficiency versus viability. The papers and corresponding 
figures used are listed in Table 3.1. 
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Table 3.1: Data resource for Chapter 4. 
Paper Figure 
Tata et al. 1997 Fig. 1, 2 
Miller et al. 1999 Fig. 4 
Cochran and Prausnitz 2001 Fig. 4 
Guzman et al. 2001 Fig. 6, 7 
Keyhani et al. 2001 Fig. 2 
Guzman et al. 2002 Fig. 3, 4 
Guzman et al. 2003 Fig. 1, 2 
Larina et al. 2005 Fig. a, b 
Mehier-Humbert et al. 2005a Fig. 1 
Hallow et al. 2006 Fig. 5 
Hallow et al. 2007 Fig. 4 
Hutcheson et al. 2010 Fig. 1 
Karshafian et al. 2010 Fig. 4, 5 
 
Experimental Methods for Chapter 7 
Cell Sorting 
 Cells were suspended at a concentration of 5-10×10
6 
cells/mL in the sorting buffer 
containing 1 x PBS (Ca/Mg
2+
 free), 1 mM EDTA, 25 mM HEPES (pH 7.0, Invitrogen) 
and 1% heat-inactivated FBS, and then sorted by FACSVantage or FACSAria Cell-
Sorting System (Becton Dickinson) using lasers and filters described previously.  
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Cell Cycle Analysis 
 The plasmid pBB14 encoding Us9-GFP (#18657, Addgene, Cambridge, MA) 
which retains GFP fluorescence quantitatively in cells following ethanol permeabilization 
(Kalejta et al. 1999) was used in US-mediated transfection for cell cycle analysis. Cells at 
a concentration of 1-2×10
6 
cells/mL were mixed by vortexing with cold absolute ethanol 
at a volume ratio of 1 to 3 and incubated for at least 1h at 4 ºC. Fixed cells were washed 
twice with PBS and resuspended in PBS with 1 vol% PI and 10 vol% RNase A 
(Invitrogen) and incubated for 30 min at RT. Samples were analyzed by FCM. A 488 nm 
laser was used for excitation and a 575/26 nm bandpass filter for emission. 
RNA Isolation and Microarray Hybridization  
Cells isolated by FACS were suspended in Trizol (Invitrogen). RNA was isolated 
and purified with PicoPure RNA Isolation Kit (Arcturus, Mountain View, CA) and RNA 
quality was verified on the Bioanalyzer RNA Pico Chip (Agilent Technologies, Palo 
Alto, CA). All the procedures followed the manufacturers’ protocols. Total RNA from 
the above extractions was processed using the RiboAmp HS kit (Arcturus) in conjunction 
with the IVT Labeling Kit (Affymetrix, Santa Clara, CA) to produce an amplified, biotin-
labeled mRNA suitable for hybridizing to GeneChip Probe Arrays (Affymetrix). Labeled 
mRNA was then hybridized to GeneChip
®
 Human Genome U133 Plus 2.0 Arrays 
(Affymetrix) according to the manufacturer’s instructions.  
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Analysis of 3’ Expression Microarray Results 
Affymetrix .CEL files were processed using the Affymetrix Expression Console 
(EC) Software Version 1.1. Files were processed using the default MAS5 3’ expression 
workflow which includes scaling all probes to a target intensity (TGT) of 500. Spiked in 
report controls used were AFFX-BioB, AFFX-BioC, AFFX-BioDn, and AFFX-CreX. 
Probe set results were further evaluated using Spotfire DecisionSite software. Probes 
were normalized across samples by Z-score calculation. In order to determine the 
differentially expressed probe sets between control and experimental groups, the t-test p-
values were calculated for each group of probe set Z-score values. Genes with p values < 
0.01 and fold changes > 2X or < -2X were considered for further analysis. In order to 
computationally cross-validate differentially expressed probe sets,  .CEL files were 
converted to expression level values using the affy and GCRMA packages of the 
Bioconductor project (www.bioconductor.org) for the R statistical programming 
environment (www.rproject.org). After GCRMA preprocessing, differentially expressed 
probe sets were identified as above. The two lists of differentially expressed probes were 
compared and found to contain 86 overlapping probe sets. Duplicate probe sets 
representing the same gene and unnamed genes were removed to leave 78 unique genes 
for further functional characterization.  





DAVID Bioinformatics Resources-http://david.abcc.ncifcrf.gov/ 
Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
1 μg of total RNA was reverse transcribed using Superscript III cDNA synthesis 
kit (Invitrogen) primed with random hexamers under conditions described by the 
supplier. cDNA from this reaction was cleaned up by gel extraction kit (QIAGEN, 
Chatsworth, CA). PCR was performed in DNA engine opticon 2 Continuous 
Fluorescence Detection System (MJ Research, Waltham, MA) using 1 μL of synthesized 
cDNA and iQ SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA) according 
to the manufacturer’s protocols. Gene specific primers for two genes (TOP2α: Forward 
5’- AGTCATTCCACGAATAACCA -3’, Reverse 5’- TTCACACCATCTTCTTGAG -
3’; GADD45α: Forward 5’- GAGAGCAGAAGACCGAAAGGA -3’, Reverse 5’- 
CACAACACCACGTTATCGGG -3’) were synthesized (Integrated DNA Technologies, 
Coralville, IA). RNA and cDNA concentration were determined by NanoDrop ND-1000 
(NanoDrop Technologies, Wilmington, DE).  
The expression levels of TOP2α and GADD45α were normalized to the 
expression of the housekeeping gene GAPDH and calculated according to the 2
-∆∆Ct
 




 The gel for DNA electrophoresis was made of 1.5%  agarose (Denville Scientific, 
Inc., Metuchen, NJ). KODAK Gel Logic 100 imaging system (Scientific Imaging 
Systems; Eastman Kodak Co., New Haven, CT) was used for imaging. 
Drug Treatment 
The drugs tested in this study were purchased from Sigma. Their names and 
concentrations are listed in Table 3.2. 
The drugs were added to the sample right before sonication at the desired 
concentrations. After US exposure, 40 µL of cells from the sample were plated in each 
well of a 6-well plate with total 2 mL growth medium under growth conditions. And 
therefore, the drug concentrations were diluted by 50 times for 8 h of incubation until 
further analysis. 
 
Experimental Methods for Chapter 8 
Samples for US Exposure 
 To test whether US exposure damages the integrity of pDNA, DNA samples were 
prepared by diluting plasmid gWizTM-GFP to a final concentration of 16 μg/mL in Opti-
MEM medium (Gibco).  
 To test whether US exposure damages the integrity of RNA, survivin-siRNA 
(Silencer pre-designed siRNA, Ambion, Austin, TX) was diluted to a final concentration 
of 100 nM in Opti-MEM medium.  
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Table 3.2: Drugs and their concentrations.  
Drugs Final Concentration during US Exposure 
Chloroquine diphosphate salt  100 µM 
Amsacrine hydrochloride  200 nM 
Mitoxantrone dihydrochloride  200 nM 
Aclarubicin  50 nM 
Etoposide  200 nM 
Ethyl methanesulfonate (EMS) 0.6, 3 mg/mL 
N-methyl-D-Aspartate (NMDA)  2 mM 
PRIMA-1 1 mM 
Taxol 16 µM 
Docetaxel  16 µM 
Bafilomycin A1   250 nM 
Tetracaine 20 µM 
 
 To test whether US exposure damages the integrity of viral vectors, adeno-
associated virus (provided courtesy of Dr. Athanasios Sambanis, Georgia Institute of 
Technology, Atlanta, GA) prepared as described previously (Tang and Sambanis 2003), 
was diluted in DMEM medium supplemented with 2% FBS to a concentration of 1.4×10
6
 
infectious units per mL. 
 Rat cortical neurons were freshly harvested from fetal E18 Sasco Sprague-Dawley 
rats (Charles River Laboratories, Wilmington, MA) with IACUC approval as previously 
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described (Cullen and LaPlaca 2006) and suspended in Neurobasal medium containing 2% 
B-27 and 500 μM L-glutamine (Gibco, Invitrogen) at a concentration of 1×10
6
 cells/mL.  
Sample Analysis 
Possible damaging effects of US were assessed by measuring possible reductions 
in DNA’s ability to transfect cells, siRNA’s ability to knockdown protein expression, and 
adeno-associated virus’ ability to transduce cells after sonication.  
To measure DNA transfection efficiency, DU145 cells were mixed with sonicated 
pDNA and Lipofectamine 2000 (Invitrogen) according to the procedure recommended by 
the manufacturer. After incubation in the growth conditions in full culture medium for 24 
h, cells were trypsinized, suspended in 300 μL PBS and placed on ice until analysis by 
FCM. Transfection efficiency was measured by determining the percentage of cells with 
green fluorescence due to GFP expression greater than untreated control cells. 
To measure survivin knockdown, DU145 cells were transfected with sonicated 
siRNA using Lipofectamine 2000, as described above. After incubation in growth 
conditions in full culture medium for 48 h, cells were trypsinized, and washed with 500 
μL PBS. A FITC-labeled anti-survivin monoclonal antibody (R&D Systems, 
Minneapolis, MN) was used to label the target protein according to the procedure 
recommended by the manufacturer. Survivin knockdown efficiency was quantified by 
measuring the decrease in mean FITC fluorescence by FCM. 
To measure adeno-associated virus transduction efficiency, sonicated adeno-
associated virus samples were incubated with HT-1080 fibrosarcoma cells (Tang and 
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Sambanis 2003). Briefly, a 375 μL sample of sonicated adeno-associated virus and 625 μl 
DMEM medium supplemented with 2% FBS were added to HT-1080 cells previously 
incubated for 1 day in 6-well plates. After incubation at 37 ºC for 1 - 2 h, 1 mL pre-
warmed DMEM medium supplemented with 18% FBS was added per well. Cells were 
then incubated and analyzed by FCM, as described above. Transduction efficiency was 
measured by determining the percentage of cells with green fluorescence due to GFP 
expression greater than untreated control cells.  
The viability of rat cortical neurons immediately after US exposure was measured 
by determining the percentage of cells lacking red fluorescence due to PI staining 
compared to untreated control cells, as previously described. 
Statistical Analysis 
A minimum of three replicates were performed for all the samples. Replicates 
were used for calculation of experimental means and standard deviations. Paired or 
unpaired Student’s t-test and analysis of variance (ANOVA) was applied to the data. 
Values of p < 0.05 were interpreted as significant. 
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 The first step of successful gene transfection is to get exogenous DNA into the 
target cells. In other words, to increase transfection efficiency, the uptake efficiency 
needs to be increased. However, cytotoxicity is found to be related to the uptake 
efficiency in US-mediated drug/gene delivery. US opens the cell membranes so as to 
allow drug/gene entry, which is desired, but at the same time it puts cells at risk of death, 
which is unwanted. Cells close to the location of cavitation are likely destroyed by US 
exposure, cells at mid-distances from the microbubbles exhibit drug/DNA uptake with 
the cell membrane temporarily opened and rapidly resealed, and cells far from the 
cavitation microbubbles remain unaffected (Guzman et al. 2001; Schlicher et al. 2006; 
Hutcheson et al. 2010). Therefore, higher molecule uptake may be achieved under strong 
US conditions, but associated with higher cell death rate. To maintain a low death rate 
under gentle exposure conditions may lead to the uptake efficiency not high enough for 
applicable drug delivery.  
 In this study, published cell viability and uptake efficiency data points from 
various studies using a variety of cell types and tissues, different size of molecules and 
US apparatus and conditions were combined and replotted as uptake efficiency versus 
viability (Tata et al. 1997; Miller et al. 1999; Cochran and Prausnitz 2001; Guzman et al. 
2001; Keyhani et al. 2001; Guzman et al. 2002; Guzman et al. 2003; Larina et al. 2005; 
Mehier-Humbert et al. 2005a; Hallow et al. 2006; Hallow et al. 2007; Hutcheson et al. 
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2010; Karshafian et al. 2010). By investigating these data, we hope to have a better 
understanding of the compromise between cell viability and uptake efficiency – the 
heterogeneous bioeffects caused by US exposure. 
 To carry out this analysis, we first define uptake efficiency as the number of 
viable cells exhibiting uptake of a marker compound divided by the total number of cells 
originally in the sample. Because some cells often die during US exposure, the non-
viable cells need to be accounted for. Some non-viable cells are present as intact cells that 
are stained with a marker of non-viability, such as propidium iodide. These non-viable 
cells are relatively easy to account for. Sometimes, cells can be lysed during US 
exposures and present as cellular debris. These non-viable cells are more difficult to 
account for, because each cell can be lysed into a variable number of pieces of debris. As 
discussed in chapter 3, we have developed a method to account for these cells turned into 
debris. Other studies have not always accounted for cells reduced to debris and therefore 
underestimate the total number of cells originally in the sample, which leads to an 
overestimate of uptake efficiency.  
 We are interested to compare uptake efficiency to cell viability. The highest 
possible uptake efficiency is equal to the cell viability, because by definition, only viable 
cells can be uptake cells. Because high uptake at high viability is desirable, in this chapter 
we test the hypothesis that high uptake at high viability cannot easily be achieved during 
US exposure. We test this hypothesis using 590 experimental data points taken from 13 
different published studies. 
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Results 
Uptake Efficiency versus Cell Viability 
 Data from 13 published papers were combined and replotted in Figure 4.1. The 
diagonal line on the graph corresponds to the maximum uptake efficiency, which equals 
cell viability. At very low viability, the uptake efficiency is close to this line, which 
means that the few remaining live cells have molecule uptake. At higher viability, the 
uptake efficiency generally diverts from the line, which means that although the US 
exposure did not cause as much cell death, only a portion of live cells had molecule 
uptake.  
 Among the 590 data points, there are 38 data points showing relatively high 
uptake (e.g., > 38%) at high viability (e.g., > 70%). It is therefore our goal to determine 
why these data points deviate from the rest and under what conditions these desirable 
delivery levels can be achieved. Several factors may contribute to these outlier results: 
the molecule size and other properties, the US conditions used, the cell type, the US 
contrast agent, the sonication temperature and the method of calculating cell viability (i.e., 
whether it accounted for cell debris generated by lysed cells). The 13 papers where we 
got these data points from, have covered a variety of cell types and tissues (e.g., DU145 
human cells, rat mammary carcinoma cells, porcine carotid artery endothelium), a broad 
range of molecule size (e.g., calcein with the molecular weight of 623 Da, dextrans with a 
molecular weight ranging from 10 kDa to 2 MDa) and US conditions (e.g., acoustic 
energy up to ~ 800 J/cm
2







and others) and sonication temperatures (room temperature, 37 ºC) and calculation of cell 





Figure 4.1: The uptake efficiency versus cell viability after US exposure. Data points 
were from literature: ▤, (Tata et al. 1997); ×, (Miller et al. 1999); □, (Cochran 
and Prausnitz 2001); ＋ , (Guzman et al. 2001); ＊ , (Keyhani et al. 2001); － , 
(Guzman et al. 2002); ▦, (Guzman et al. 2003); ■, (Larina et al. 2005); ▢, (Mehier-
Humbert et al. 2005a); ▣, (Hallow et al. 2006); ▥, (Hutcheson et al. 2010); ●, 
(Karshafian et al. 2010). Each data point represents the average of n ≥ 3 replicates. 
The solid line is where uptake efficiency equals cell viability. The dash line is where 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.2: The uptake efficiency versus cell viability after US exposure. Data points 
were from literature (see Figure 4.1). Each data point represents the average of n ≥ 
3 replicates. The solid line is where uptake efficiency equals cell viability. The dash 
line is where the uptake efficiency equals 38%. (a) Data from studies using US 
energy lower (●) and higher (▥) than 100 J/cm2. (b) Data from studies using 
megahertz US (● ) and kilohertz US (▥ ). (c) Data from studies using large 
molecules (●, MW > 1 kDa, e.g., dextran, BSA and DNA) and small molecules (▥, 
MW < 1 kDa, e.g., calcein). (d) Data from studies using KHCT cells (●), prostate 
cancer cells (▥), CHO cells (▦), AoSMC cells (□), rat mammary cells (▣), ex vivo 
artery (×) and other cell lines (+). (e) Data from studies of US exposure at 37 ºC (●) 
and room temperature (▥). (f) Data from studies using Definity® (●), Optison® (▥) 
and other contrast agents (×). (g) Data from studies accounting (● ) and not 
accounting (▥) for cell debris in the calculation. 
 
 We put these 590 data points in groups according to the methods (e.g., whether or 
not accounting for cell debris, sonication temperature, US contrast agent, cell/tissue type, 
uptake molecule, US frequency and energy) used in the studies (Figure 4.2) and did a 
closer examination of the 38 outlier data (uptake threshold = 38%). To identify which 
parameters might influence whether a data point falls among the outliers, we looked for 
situations where one parameter value was much more highly represented among the 
outlier points. We considered these differences based on two types of analysis: (i) among 
the 38 outlier data points, we identified the fractions that were in each parameter group 
(Figure 4.3a) and (ii) among all the data points at each parameter value, we identified the 




Figure 4.3: (a) The fraction of outlier data points (i.e., with uptake efficiency > 38%) 
that belong to each group. (b) The fraction of data points in each group that fall 
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 As shown in Figure 4.3, there was no apparent preference for low (< 100 J/cm
2
) 
vs. high (> 100 J/cm
2
) acoustic energy or low (< 1 MHz) vs. high (≥ 1 MHz) US 
frequency. Among the uptake molecules, there was a higher incidence of high (> 1 kDa) 
vs. low (< 1 kDa) molecular weight compounds. We believe this difference is an artifact 
of the data set, such that these studies using conditions associated with the outlier data 
happened to use high molecular weight dextrans. The literature shows that uptake of high 
molecular weight molecules is not easier or more extensive than low molecular weight 
molecules (Guzman et al. 2002; Larina et al. 2005; Mehier-Humbert et al. 2005a; 
Karshafian et al. 2010). Moreover, the inert matter compounds used in these studies are 
not expected to affect viability. Similarly, the outlier data points were not associated with 
a particular cell type, although one of the studies generating the outlier data happened to 
use rat mammary carcinoma cells. 
 We did, however, notice that the outlier data were associated with sonication at 
higher temperature of 37 °C, rather than room temperature. 89% of the 38 outlier data 
were from the studies of US exposure at 37 °C (Figure 4.3a) and 71% of the data from 
the studies of US exposure at 37 °C were above the uptake threshold (Figure 4.3b). 
Among the 38 outlier data, 30% were from studies using Definity
®
 as a contrast agent 
and 55% were from studies using Optison
®
 (Figure 4.3a). While 65% of the data from the 
studies using Definity
®
 were outlier and only 4% of the data from the studies using 
Optison
®
 were above the uptake threshold (Figure 4.3b). Thus, US contrast agents may 
also contribute to the higher uptake efficiency. Finally, we noticed that whether 
accounting for cell debris in the calculation of cell viability made a big difference. 
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Among the 38 outlier data, 90% did not account for cell debris (Figure 4.3a) and 50% of 
data that did not account for cell debris were outlier, while only 0.7% of the data that 
accounted for cell debris were above the uptake threshold (Figure 4.3b). In the following 
section we analyze the effects of these three features of the outlier cells. 
The Influence of Temperature and US Contrast Agents 
 To test the effect of sonication temperature and the type of contrast agent on 
uptake efficiency, we conducted US exposure using DU145 cells as target cells and 
FITC-dextran (70 kDa) as the uptake marker compound with 1 MHz US. As shown in 
Figure 4.4, US exposure at the temperature of 37 ºC resulted in higher uptake efficiency 
in the presence of Definity
®




 led to higher uptake efficiency 
compared to Optison
® 
at both temperatures. Under all these four sonication conditions, 
similar cell viability (~ 55%, p > 0.05) was achieved. 
 Figure 4.4 shows that increasing temperature to 37 ºC in the presence of Definity
®
 
increased uptake efficiency by 51±34% relative to cells sonicated at room temperature. 
Changing temperature in the presence of Optison
®
 did not have a significant effect on 
uptake efficiency. It is worth noting that 30% of the 38 outlier data points were from the 
studies of US exposure at 37 ºC in the presence of Definity
®
. Thus, it is possible that if 
the data points generated at room temperature that show lower uptake had instead been 
taken at 37 ºC, they would have had higher uptake efficiency. This is in agreement with 
previous studies that showed enhanced delivery at elevated temperature (Kim et al. 1996; 




Figure 4.4: The overall uptake efficiency among DU145 cells after US exposure at 23 
ºC or 37 ºC with 0.1 vol% Definity
®
 or 2 vol% Optison
®
 (*p < 0.05, n = 3 replicates, 
data points show average ± SD). US pressure: 0.39 MPa, duty cycle: 25%, total 
treatment time: 1 s. 
 
 Figure 4.4 also shows that 0.1% Definity
®
 led to 83% – 136% greater uptake 
efficiency than 2% Optison
®
 depending on the temperature. These concentrations were 
selected to get an equal bubble concentration (~ 1.2×10
7
 bubbles/mL), because the native 
microbubble concentration in Definity
®
 is 20-fold higher than that in Optison
®
 
(Karshafian et al. 2010). And these concentrations were in the range of what the reference 
studies used. Among the data from the studies using Optison
®


























0.067 - 20 vol%), 75% were using the concentration of ~ 2% (0.67 – 3.3 vol%). Among 
the data from the studies using Definity
®
 (the concentration range: 0.067 – 13.2 vol%), 
12% were using the concentration of ~ 0.1% (0.067 – 0.67 vol%). It is possible that if the 
data points generated using 2% Optison
® 
that show lower uptake had instead been taken 
using 0.1% Definity
®
, they would have had higher uptake efficiency. It is also expected 
that we may get higher uptake efficiency if higher Definity
®
 concentration is used, as 
shown previously (Moran et al. 2002; Li et al. 2004; Miller and Dou 2004b; Koike et al. 
2005; Rahim et al. 2006; Karshafian et al. 2010; King et al. 2010).  
 A different temperature or US contrast agent may improve the molecule uptake 
without affecting cell viability, but these may not be the only two factors. Therefore we 
finally looked into the issue of cell debris in the calculation of uptake efficiency and cell 
viability.  
Accounting for Cell Debris in the Calculation of Uptake Efficiency and Viability 
 As shown in Figure 4.3, whether or not accounting for cell debris in the 
calculation of cell viability made a big difference. If cells reduced to debris are not 
accounted for, then uptake efficiency and cell viability can both be increased (i.e., the 
denominator would be smaller in the calculation of percent cells with uptake and 
viability), which would significantly affect our analysis. Although we do not have access 
to the original data and it would be very difficult to account for cell debris after the fact in 
those studies with high uptake at high viability, we do have access to the original data for 
some of the data points that were generated by accounting for cell debris, and can work 
backwards to find out what the uptake efficiency and cell viability would be if cell debris 
had not been accounted for.   
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 Using this approach, we replotted 280 data points from a large study using DU145 
cells and calcein with 1.1 and 3.1 MHz US in Figure 4.5a (Hallow et al. 2006). In this 
figure, the same 280 experimental data points were each plotted twice in two different 
formats: accounting and not accounting for cell debris in the calculation. Accounting for 
the debris, the cell viability is 
     
     
 (see Chapter 3). Not accounting for cell debris, the 
viability is N1/Ns. This analysis shows that not accounting for cell debris in the cell 
viability calculation has a significant effect. If these data are presented without 
accounting for cell debris, many of the data points are in the region of high uptake at high 
viability. If presented with accounting for cell debris, then the data points are all below 
38%, the uptake efficiency threshold (Figure 4.5a).  
 We next calculated the difference in uptake efficiency and cell viability for each 
of the pairs of data points with and without accounting for cell debris and present them in 
Figure 4.5b and 4.5c. These graphs show that both uptake efficiency and cell viability can  
be increased by tens of percent if cell debris is not accounted for. In addition, the degree 
of deviation increases with increasing energy for both uptake efficiency and cell viability 
(ANOVA, p < 0.01). Although the data are not shown graphically, the absolute value for 
uptake efficiency (calculated without accounting for cell debris) also increases with 
increasing energy (ANOVA, p < 0.05), which means that the greatest deviations are seen 









































































Figure 4.5: (a) The uptake efficiency versus cell viability after US exposure. White 
diamonds represent data in the calculation accounting for cell debris caused by US 
exposure. Black circles represent the same experimental data but in the calculation 
not accounting for cell debris. Each data point represents the average of n ≥ 3 
replicates. The solid line is where uptake efficiency equals cell viability. The dash 
line is where uptake efficiency equals 38%. (b, c) The differences between the two 
ways in calculating uptake efficiency and cell viability over a range of acoustic 
energy intensities. (b) Δuptake and (c) Δviability were calculated by subtracting the 
data in the calculation accounting for cell debris from that in the calculation not 
accounting for cell debris. 
 
Discussion 
 Various US apparatus systems have been designed and a variety of US exposure 
conditions (e.g., frequency, energy intensity, pulse length, acoustic pressure) were tested 
on different types of cells and tissues both in vitro and in vivo to facilitate drug/gene 
delivery (Mitragotri 2005). Although the bioeffects caused by US exposure was found to 
differ due to the US conditions and cell/tissue types, nearly all the studies reported the 
heterogeneous bioeffects. It is difficult to achieve both high viability and high uptake 
efficiency or transfection efficiency.  
 US temporarily opens cell membranes and allows molecules to diffuse into cells. 
The diffusion may be enhanced by increasing temperature (Kim et al. 1996; Poling et al. 
2001; Nozaki et al. 2003; Zarnitsyn and Prausnitz 2004). In this study, US exposure at 37 
ºC increased uptake efficiency without decreasing the cell viability compared to 
sonication at RT. Similar results were found in some previous drug/gene delivery studies 
using US exposure (Kim et al. 1996; Nozaki et al. 2003; Zarnitsyn and Prausnitz 2004) 
and other delivery systems (Croaker et al. 1990; Fregeau and Bleackley 1991; Rols et al. 
1994).  
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 The bioeffects mediated by US may be dependent on the US contrast agent 
(Moran et al. 2000; Chen et al. 2002; Moran et al. 2002; Sonne et al. 2003; Li et al. 2004; 
Miller and Dou 2004b; Koike et al. 2005; Rahim et al. 2006; McDannold et al. 2007; 




 were tested in this 
study at a concentration of 0.1 and 2 vol%, separately. This comparison of contrast agents 
is complicated because the concentrations were not the same. In terms of bubble 
concentration, 2% Optison
®
 corresponds to ~ 1.2×10
7
 bubbles/mL and 0.1% Definity
®
 
corresponds to ~ 1.2×10
7
 bubbles/mL. In terms of volume fraction of bubbles, 2% 
Optison
®
 corresponds to 0.04 vol% gas and 0.1% Definity
®
 corresponds to 0.005 vol% 
gas. Under the same US conditions, Definity
®
 showed higher uptake efficiency, which is 
consistent with some previous studies (Moran et al. 2000; Li et al. 2004; Miller and Dou 
2004b; King et al. 2010). It is also expected that higher uptake efficiency may be reached 
if higher Definity
®
 concentration is used, as shown previously (Koike et al. 2005; Rahim 
et al. 2006; Karshafian et al. 2010).  
 US generates heterogeneous bioeffects among sonicated cells, including (i) viable 
cells that appear unaffected, (ii) viable cells reversibly permeabilized, as evidenced by 
intracellular uptake of molecules, (iii) cells that appear to be viable shortly after 
sonication, but later undergo apoptosis and die, and (iv) nonviable cells during sonication, 
as shown by an irreversible loss of the plasma membrane barrier or lysis of the cell into 
debris (Hutcheson et al. 2010). Quantification of cells lysed into debris was difficult, 
because a single lysed cell produced multiple debris events. By investigating the methods 
in related literature, we found whether or not accounting for cell debris in the calculation 
of uptake efficiency and viability made a significant difference. Without accounting for 
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the debris from lysed cells, the uptake efficiency and viability were calculated as those 
among the intact cells, while cells that were destroyed by US were omitted. Therefore, 
the uptake efficiency in live cells seems high, but the overall, actual uptake efficiency 
may be much lower (Figure 4.5). As shown in Figure 4.2g and 4.3, 90% of the 38 outlier 
data points did not account for cell debris and 50% of data points that did not account for 
cell debris were among the outliers, while only 0.7% of the data that accounted for cell 
debris were among the outliers. Among the data points in Figure 4.5, up to 90% of cells 
could be turned into debris by US, depending on the conditions used. Therefore, not 
accounting for cell debris in the calculation could not completely reflect the bioeffects 
caused by US exposure.  
 This is more significant under strong US conditions when more cell debris is 
possibly generated (Ns < N0 and Ts > T0) (Figure 4.5). Under gentle US conditions when 
most cells remain intact, Ns ≈ N0 and Ts ≈ T0. Therefore, the cell viability is 
     
     
 ≈ N1/Ns, 
and accounting for cell debris in the calculation of viability may cause some noise 
(Figure 4.5c) due to the measurement of three more numbers, N0, T0 and Ts. Since the 
overall uptake efficiency is the uptake efficiency of live cells multiplied by the overall 
viability, not accounting for debris also affects the calculation of uptake efficiency by 
making it higher. 
 To summarize, after investigating the quantitative bioeffects caused by US 
exposure in the previous studies, we found regardless the cell types, US conditions, 
sonication temperature or US contrast agents, the bioeffects of US exposure are 
heterogeneous, which means it is difficult to achieve high uptake efficiency and low 
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cytotoxity at the same time. To reflect the actual bioeffects, the results of uptake and 
viability should be reported with the cell debris taken into consideration.  
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 Because US-mediated drug/gene delivery caused heterogeneous bioeffects, to 
increase the overall gene transfection efficiency, it is a challenge to find an optimal US 
condition that compromises the viability and transfection efficiency. In this study, DU145 
cells were exposed with 1 MHz US for gene transfection. US exposure conditions were 
optimized by testing these parameters: acoustic pressure and energy intensity, US pulse 
length and duty cycle, US contrast agent and the osmotic condition. We expected to find 
an US condition that maintains low death rate (~ 80% cell viability) and at the same time 
achieves a transfection efficiency as high as possible.  
Results 
US Pressure and Energy Intensity 
   Three acoustic pressures were tested with different total treatment time, which 
gave three acoustic energy intensities at each pressure: 200, 306 and 400 J/cm
2 
(Figure 
5.1). The transfection efficiency in live cells increased and cell viability decreased with 
the increase of US pressure (two-way ANOVA, p < 0.05). US exposure at 0.78 MPa for 1 
min (the energy intensity of 306 J/cm
2
) showed the highest transfection efficiency (~ 
21%) in all the cells with the average cell viability of 84%. 
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   (a)                                            (b)                                       (c) 
Figure 5.1: Transfection efficiency among all the cells (a) and live cells (b) and the 
cell viability (c) at 8 h after US exposure at different acoustic pressures and energy 
intensities (n ≥ 3 replicates, data points show average ± SD) with a pulse length of 
0.25 ms, duty cycle of 25% and Definity
®
 concentration of 2 vol%. Black bar: 
acoustic energy of 200 J/cm
2
. Grey bar: acoustic energy of 306 J/cm
2
. White bar: 





 The pulse length or pulse repetition frequency was previously found to affect cell 
viability and transfection efficiency (Tata et al. 1997; Huber et al. 1999). In our study, the 
transfection efficiency in live cells increased and cell viability decreased with the 
increase of pulse length (one-way ANOVA, p < 0.01).  US exposure at the pulse length 
of 0.25 ms showed an average cell viability of 75% with the average transfection 









































































                     (a)                                                                (b) 
Figure 5.2: Cell viability (a) and transfection efficiency (b) at 8 h after US exposure 
at different pulse length (n ≥ 3 replicates, data points show average ± SD) with the 
acoustic pressure of 0.78 MPa, energy intensity of 102 J/cm
2
, duty cycle of 4%, total 
treatment time of 125 s and the Definity
®
 concentration of 2 vol%. Rectangle: 
transfection efficiency in live cells. Triangle: transfection efficiency in all the cells. 
 
Duty Cycle 
 We tested the influence of duty cycle at the pulse length of 0.25 ms and 0.5 ms 
(Figure 5.3). Overall, the bioeffects at different duty cycles were significant (one-way 
ANOVA, p < 0.01), which is consistent with some previous studies (Larina et al. 2005; 
Pan et al. 2005). US exposure at the duty cycle of 25% showed comparatively both high 
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                 (a)                                                                (b) 
 
                   (c)                                                                (d) 
Figure 5.3: Cell viability (a, c) and transfection efficiency (b, d) at 8 h after US 
exposure at different duty cycle (n ≥ 3 replicates, data points show average ± SD) 
with the acoustic pressure of 0.783 MPa, energy intensity of 102 J/cm
2
, pulse length 
of 0.25 (a, b) or 0.5 (c, d) ms, and the Definity
®
 concentration of 2 vol%. Rectangle: 




















































































US Contrast Agent 
 The concentration of US contrast agent affects microbubble-cell spacing and 
therefore has been shown to affect the bioeffects caused by US exposure (Guzman et al. 
2003; Ohl et al. 2006; Miller et al. 2008). With the increase of Definity
®
 concentration, 
cell viability decreased and the transfection efficiency in live cells increased reaching a 
maximum, beyond which it decreased (one-way ANOVA, p < 0.01). Similar results were 
found in other studies of US-mediated drug delivery (Karshafian et al. 2010). At the 
concentrations we tested, adding 2 vol% of Definity
®
 to the sonication samples showed 
an average cell viability of 77% with the average transfection efficiency of 18% among 
all the cells (Figure 5.4). 
 
 
         (a)                                                                (b) 
Figure 5.4: Cell viability (a) and transfection efficiency (b) at 8 h after US exposure 
at different Definity
®
 concentration (n ≥ 3 replicates, data points show average ± 
SD) with the acoustic pressure of 0.783 MPa, energy intensity of 306 J/cm
2
, duty 













































 The osmotic pressure of the external aqueous medium may cause cells to swell 
and make the cell membranes more permeable for drug/gene delivery. The microbubble-
cell spacing may be changed to make cells easier to be targeted by US. The osmotically 
driven convective flow may also facilitate drug/gene delivery. As a result shown in 
Figure 5.5, transfection efficiency was increased when cells were suspended in a low 
osmotic strength buffer of RPMI mixed with water at a RPMI:water volume ratio of 3:1, 
compared to cells sonicated in pure RPMI medium. 
 
 
                 (a)                                                                   (b) 
Figure 5.5: Cell viability (a) and transfection efficiency (b) under different osmotic 
conditions. The volume ratio of water over RPMI medium is 0 to 1 or 1 to 3. (n ≥ 3 
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*
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MPa, total treatment time of 1 min, energy intensity of 306 J/cm
2
, duty cycle of 
25%, the pulse length of 0.25 ms and the Definity
®
 concentration of 1 vol%. 
   
Discussion 
 To find an optimal US condition for gene transfection, we measured the cell 
viability and transfection efficiency at different acoustic pressures, energy intensities, 
pulse lengths, duty cycles, the concentrations of Definity
®
 US contrast agent, and the 
osmotic conditions of the extracellular medium. 
 The bioeffects caused by US was previously found to be related to the acoustic 
energy intensity, but at higher energy intensities (i.e., > 100 J/cm
2
) where the US 
exposure was well above the cavitation threshold, this dependence was not that 
significant (Guzman et al. 2001; Zarnitsyn and Prausnitz 2004). Our data showed the US 
pressure had a strong impact on gene transfection and cell viability. Pulse length affects 
the threshold for gas fragmentation and inertial cavitation nucleation caused by US 
(Atchley et al. 1988; Chen et al. 2003c; Miller and Dou 2004a). In a pulse length long 
enough, additional microbubbles may be activated due to the fragmentation of mother 
bubbles into daughter microbubbles and therefore a cascade of cavitation may be 
generated (Chen et al. 2003c).  
 Under the same acoustic energy intensity, the bioeffects mediated by US exposure 
were found to increase with the increasing pulse length (Kober et al. 1989; Brayman and 
Miller 1999; Huber et al. 1999; Chen et al. 2003b; Chen et al. 2003c; Tu et al. 2006). We 
got comparatively higher viability and transfection efficiency in all the cells at the pulse 
length of 0.25 ms and 0.5 ms. Changing duty cycle did not affect the bioeffects mediated 
by US. However, longer duty cycle may lead to the increase of temperature. We 
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measured the temperatures of sonication samples before and immediately after US 
exposure. The changes of temperature in the sonication samples were less than 1 ºC at 
most duty cycles tested, except the duty cycle of 100% when continuous US was applied, 
rather than pulsed US, and a temperature rise of 1.2 ºC was measured. The transfection 
efficiency was increased by changing the osmotic pressure of the extracellular medium. 
However, to better mimic the in vivo conditions, we choose to use pure RPMI as the 
medium for cell samples.   
Based on these data, the following parameters were chosen for a typical US 
condition to facilitate gene transfection in DU145 cells in vitro. 
 Frequency: 1 MHz 
 Peak-to-peak pressure: 0.78 MPa, 
 Duty cycle: 25%, 
 Pulse length: 0.25 ms, 
 Total treatment time: 1 min, 
 Acoustic energy intensity: 306 J/cm2, 




CHAPTER 6: DNA TRAFFICKING AND LOCALIZATION 
 
Introduction 
 DNA entry to the cells is only the first step for gene transfection. The exogenous 
DNA has to traverse the cytoplasm and enter the nucleus prior to transcription and 
translation. This process needs to be quick since nucleases in the cytoplasm start to 
degrade exogenous DNA in minutes (Lechardeur et al. 1999; Pollard et al. 2001). 
However, the passive diffusion of plasmid DNA in the cytoplasm is generally very slow, 
especially for DNA molecules lager than 1000 base pair (660 kDa), because the multiple 
cytoskeletal elements (e.g., microfilaments, microtubules and intermediated filaments) in 
the cytoplasm form a complex and crowded latticework that significantly impedes the 
diffusion of large molecules (Lukacs et al. 2000). It has been shown in non-viral gene 
transfection that a certain amount of plasmid DNA stays in the cytoplasm after entering 
the cell, which is considered as one of the reasons for low transfection efficiency by non-
viral gene delivery methods (Vaughan et al. 2006). Therefore, it is important to better 
understand DNA trafficking in cytoplasm to enhance gene transfection. 
 Current studies on DNA trafficking are mainly focused on chemical gene delivery 
systems (Colin et al. 2000; Fisher et al. 2000; Tachibana et al. 2002; Akita et al. 2004), 
where multiple trafficking steps are required, such as cell attachment, endocytosis and 
entrapment into endocytic vesicles, maturation of endosomes into lysosomes, escape 
from vesicular compartments, migration toward the nucleus periphery, dissociation 
between carriers and foreign DNA, and finally entry of DNA into the nucleus. There are 
fewer reports of DNA trafficking studies using physical delivery systems such as US 
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(Duvshani-Eshet et al. 2006) , electroporation (Golzio et al. 2002) and microinjection 
(Wilson et al. 1999; Vaughan et al. 2008). US-mediated gene transfection temporarily 
opens cell membranes and does not require endocytosis to allow pDNA entry. US was 
found to deliver pDNA to the periphery of cell nucleus and facilitate rapid transfection, 
possibly due to the alteration of cytoskeleton (Skorpikova et al. 2001; Raz et al. 2005), 
although this only happened to a small fraction of cells.  
 In this study, we use both flow cytometry and confocal microscopy to analyze the 
localization of pDNA in cell cytoplasm and nuclei post US exposure both qualitatively 
and quantitatively. We hypothesize that DNA introduced into the cytoplasm during 
sonication is either transported into the nucleus within hours or removed by 
autophagosomes/autophagolysosomes. DNA that reaches and remains in the nucleus is 
efficiently transcribed and translated to produce its expression product. We expect to 
have a better understanding of the kinetics of pDNA uptake, gene expression, pDNA 
colocalization in the cell nuclei and other organelles in the cytoplasm. 
 
Results 
Heterogeneous Bioeffects Caused by US Exposure 
 We first looked at the heterogeneous bioeffects among viable cells after 8-h 
incubation post US exposure. Three kinds of viable cells were observed under confocal 
microscope (Figure 6.1): cells with pDNA uptake (cells with red fluorescence), cells with 
GFP transfection (cells with green fluorescence) and cells with neither of these 
bioeffects. To achieve successful gene transfection, it is necessary to get DNA into the 
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cell nuclei. We further evaluated the capability of US to deliver DNA to the nuclei by 




Figure 6.1: Confocal micrograph showing Cy3-labeled pDNA uptake (red) and GFP 
expression (green). Cells were harvested after incubation for 8 h post US exposure 
and stained with a nuclear counterstain, trihydrochloride (blue). US exposure 
conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min with a 
pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
 concentration of 1 vol%. 
 








Figure 6.2: Representative microscopy images (two images at each time point) of 
Cy3-labled pDNA and cell nuclei at 30 min (a), 8 h (b), 16 h (c) and 24 h (d) post US 
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exposure. The red color indicates pDNA. The blue color indicates cell nuclei. The 
yellow pseudo-color indicates colocalization. 
 
 Representative microscopy images showed the colocalization of pDNA with the 
cell nuclei immediately after US exposure (Figure 6.2a), which indicated US could 
deliver pDNA to the nuclei to facilitate rapid gene transfection. The colocalization of 
pDNA and nuclei was observed from 30 min to 24 h post US exposure. At earlier time 
points post US exposure, pDNA spread out in cells as many small red dots under the 
confocal microscope (Figure 6.2a). Over time, the red dots became less in number and 
larger in size (Figure 6.2b, c), indicating pDNA aggregated in the perinuclear region of 
the cell and were possibly “packaged together” by some intracellular organelles. 
Therefore the light intensity of red fluorescent and the pseudo-yellow color indicating 
colocalization right after US exposure was not as strong as we observed at later time 
points. It was hard to find the location of pDNA at later time points (Figure 6.2d) 
presumably because of the less number of pDNA left due to degradation or cell division. 
Quantitative Analysis from the Cellular Perspective 
 The microscopy images showed that US was able to deliver DNA to the cell 
nuclei within a short time after the treatment. We next investigated DNA delivery from 
the cellular perspective by measuring the fraction of cells containing DNA (Figure 6.3a), 
with DNA in their nuclei (Figure 6.3b) and the fraction of cells with GFP expression 
(Figure 6.3c). Immediately after US exposure, about 32% of all the cells showed labeled 
pDNA uptake (Figure 6.3a). The uptake efficiency decreased over time (one-way 
ANOVA, p < 0.01) possibly due to DNA degradation and cell division. The uptake 
efficiency determined by FCM (black triangles, Figure 6.3a) was higher than that 
 71 
determined by confocal microscopy (white triangles, Figure 6.3a) (two-way ANOVA, p < 
0.05), mainly because FCM is more sensitive. It was observed that at 30 min after US 
exposure, the red dots indicating pDNA were small in size and weak in light intensity, 
therefore hard to recognize with naked eyes (Figure 6.2a). Counting cells under 
microscope gave a lower fraction of cells with DNA uptake, compared to the 
measurement using FCM.  
 Figure 6.3b shows the fraction of cells with pDNA in the nuclei determined by 
confocal microscopy and 3D image analysis. Previous work has suggested that cells only 
need three plasmid copies per nucleus to express detectable transgene product (Ludtke et 
al. 2002). We found that 30 min after US exposure about 12% of cells had pDNA in the 
nuclei, at 4 h this number became 14% (Figure 6.3b). Gene transfection was observed as 
early as 4 h (~ 10%) post US exposure (Figure 6.3c). Transfection efficiency increased 
over time, peaked at 8 h (~ 12.3%) and then decreased (one-way ANOVA, p < 0.01). 
Similar results were found in some previous studies (Mehier-Humbert et al. 2005b; Ohl et 
al. 2006). The transfection efficiency of unlabeled pDNA was higher than labeled pDNA 
(two-way ANOVA, p < 0.01) probably because the side effects of Cy5 labeling, which 
was investigated and discussed previously (Gasiorowski and Dean 2005).  
 It was suggested that once pDNA entered the cell nucleus, protein expression took 
place within 3 h (Mehier-Humbert et al. 2005b). The rapid transfection observed after US 
exposure together with the colocalization of pDNA in the cell nuclei confirmed that US 
could not only open the cell membranes and allow pDNA to diffuse into the cytoplasm, 
but also possibly deliver pDNA to the perinuclear region to facilitate nuclear uptake or 
directly to the nuclei and thus achieve rapid gene transfection. Several reasons could 
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possibly contribute to the decrease of GFP-positive cells at 20 h post-transfection. Firstly, 
naked pDNA could be partially degraded by DNases in cytoplasm over time. Secondly, 
the half-life of GFP in mammalian cells is between 20 and 30 h  (Corish and Tyler-Smith 
1999). Thirdly, the decrease could also be explained by cell growth and division, thereby 
reducing the quantity of GFP copies per cell.  
 
 
                (a)                                             (b)                                          (c) 
Figure 6.3: (a) Kinetics of labeled pDNA uptake determined by FCM (black triangle, 
n ≥ 4 replicates, data points show average ± SD, one-way ANOVA, p < 0.01) and 
microscopy (white triangle). (b) The fraction of cells with labeled pDNA colocalized 
with the nuclei determined by microscopy. (c) Transfection efficiency of labeled 
pDNA (black rectangle) and unlabeled pDNA (white rectangle) determined by FCM 
(n ≥ 4 replicates, data points show average ± SD, two-way ANOVA, p < 0.01).  (a, b) 
Data points from quantitative microscopy images analysis represent the average ± 
SD of 3 biological samples with ≥ 5 images for each (one-way ANOVA, p > 0.05). 
Totally over 100 cells at each time point were examined under microscope. US 
exposure conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min 
with a pulse length of 0.25 ms at a duty cycle of 25%, Definity
®








































































































 Overall, we found ~ 30% of cells had DNA uptake right after US exposure and 
most of these uptake cells had pDNA in the nuclei. We found the maximum gene 
transfection efficiency was ~ 12% at 8 h post US exposure, which is close to the fraction 
of cells that had pDNA in the nuclei (two-way ANOVA, p > 0.05). These findings 
support our hypothesis that DNA that reaches and remains in the nucleus is efficiently 
transcribed and translated to produce its expression product. 
Quantitative Analysis from the DNA Perspective 
 We next analyzed DNA delivery from the DNA perspective by determining the 
fraction of DNA delivered into the cell nuclei. Right after US exposure, nearly 30% of 
pDNA were colocalized with cell nuclei and this number remained nearly constant till 24 
h of incubation (Figure 6.4, one-way ANOVA, p > 0.05). This result confirmed that US 
was able to deliver pDNA directly to the nuclei and facilitate rapid transgene expression. 
 We also randomly picked individual cells with pDNA uptake, measured the 
fraction of pDNA in the nucleus per cell and put it in the histograms (Figure 6.5). The 
geometric means were found similar in each histogram at different time point post US 
exposure, which were close to the results in Figure 6.4, that is, 25 - 30% of DNA were 
colocalized with the nuclei when the whole microscopy images were analyzed.   
 These histograms confirmed that most of the cells with DNA uptake had at least 
some DNA in the nuclei, as shown previously in Figure 6.3. At early time point (30 min 
post US exposure), cells had a variety amount of DNA in the nuclei (Figure 6.5a). At 
later time points (e.g., 24 h post US exposure), cells had most of DNA either in the nuclei 
of in the cytoplasm (Figure 6.5d). These results were consistent with the previous 
observations under microscope that DNA spread out in cells as many small red dots 
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initially and aggregated, became larger in size but less in number over time (Figure 6.2), 
therefore we did not see many cells with the fraction of DNA in the nuclei in the range of 




Figure 6.4: The fraction of Cy3-labeled pDNA that colocalized with the cell nuclei.  
Data points represent the average ± SD of 3 biological samples with ≥ 5 images for 
each (one-way ANOVA, p > 0.05). Totally over 100 cells at each time point were 
examined under microscope.  

































Figure 6.5: Histograms of the fraction of Cy3-labled pDNA in the cell nucleus per 
cell. Cells were examined under microscope at (a) 30 min (n = 29), (b) 8 h (n = 50), (c) 
16 h (n = 19) and (d) 24 h (n = 25) post US exposure at the pressure amplitude of 
0.78 MPa for 1 min with a pulse length of 0.25 ms at a duty cycle of 25% and 
Definity
®
 concentration of 1 vol%. 
 
DNA Trafficking in Cytoplasm post US Exposure 
 We previously found US was able to deliver DNA to the cell nuclei and we were 
also interested in the location of the rest of DNA in the cytoplasm. Figure 6.2 suggested 
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the cell and were possibly “packaged together” by some intracellular organelles. To 
better understand it, we used specific antibodies to label early endosomes, late endosomes 
and lysosomes separately in cells incubated for 0 ~ 24 h after US-mediated gene 
transfection, and looked for the colocalization of pDNA with these organelles. Under 
confocal microscope, colocalization was not found between pDNA and early endosomes 
(Figure 6.6a) or late endosomes (Figure 6.6b) at all the time points post US exposure. In 
most cases, pDNA was not found colocalized with lysosomes (Figure 6.6c), except two 
colocalization cases was found in all the images (2 out of ~ 700 cells) investigated 
(Figure 6.6d). These results indicated that US-mediated gene delivery was not through 
endocytosis. 
 We also used LysoTracker
®
 to generally label acidic organelles including 
endosomes/lysosomes and autophagosomes/autophagolysosomes. Colocalization was 
found within 30 min after US exposure (Figure 6.7), which indicated that pDNA in 
cytoplasm was entrapped by autophagosomes/autophagolysosomes and possibly 
transported or degraded by autophagosomes/autophagolysosomes, since pDNA were not 
found to colocalize with specifically antibody-labeled early endosomes, late endosomes 
or lysosomes (Figure 6.6). 
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Figure 6.6: Representative microscopy images of Cy3-labled pDNA and antibody-
labeled early endosomes (a), late endosomes (b) and lysosomes (c, d) in cells 






indicates early endosomes (a), late endosomes (b) and lysosomes (c, d). The yellow 




Figure 6.7: Representative microscopy images of Cy3-labled pDNA and 
LysoTracker
®
-labeled endosomes/lysosomes and autophagosomes/ 
autophagolysosomes in cells at 30min, 2 h, 4 h and 24 h post US exposure. The red 
color indicates pDNA. The green color indicates endosomes/lysosomes and 
autophagosomes/autophagolysosomes. The yellow color indicates colocalization (also 
indicated by arrows). 
 
Ying Liu                    September 2010
30 min 2 h
4 h 24 h
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 We determined the fraction of pDNA colocalized with autophagosomes/ 
autophagolysosomes and put the results together with the fraction of pDNA colocalized 
with the cell nuclei (data from Figure 6.4). As shown in Figure 6.8, 30 min after US 
exposure, about the same amount of pDNA were colocalized with the cell nuclei and 
autophagosomes/autophagolysosomes, and the rest of pDNA (~ 60%) were “free” in the 
cytoplasm. At 4 h post US exposure, most of the pDNA in the cytoplasm were 
colocalized with autophagosomes/autophagolysosomes, leaving only ~ 10% “free” in the 
cytoplasm (p < 0.01). And at 24 h, all the pDNA that were not in the cell nuclei were 





Figure 6.8: The fraction of Cy3-labeled pDNA that colocalized with the cell nuclei 
(black bar, one-way ANOVA, p > 0.05), autophagosomes/autophagolysosomes (grey 

























ANOVA, p < 0.01). Data points represent the average ± SD of 3 biological samples 




 We studied the capability of US to deliver DNA in the cell nuclei from the 
cellular perspective and DNA perspective. The results support our hypothesis that DNA 
introduced into the cytoplasm during sonication is either transported into the nucleus 
within hours or removed by autophagosomes/autophagolysosomes, and DNA that reaches 
and remains in the nucleus is efficiently transcribed and translated to produce its 
expression product. We found that within 30 min after sonication, up to ~ 30% of cells 
had DNA uptake and most had a portion of the DNA already in the nuclei (Figure 6.3). 
Overall, ~ 30% of intracellular DNA was in the nuclei, ~ 30% was in the 
autophagosomes/autophagolysosomes and the rest was free in the cytoplasm (Figure 6.8). 
After 4 h, the percentage of cells with DNA uptake decreased to ~20% and half of those 
cells (i.e. ~ 10% of all cells) exhibited expression of the reporter protein GFP (Figure 6.3). 
The percentage of intracellular DNA remains at ~ 30% in the nuclei, but increased to ~ 
60% in the autophagosomes/autophagolysosomes, leaving just ~ 10% free in cytoplasm 
(Figure 6.8). At later time up to 24 h, the percentage of cells with DNA uptake decreased 
continuously to ~ 10%, with most of these cells exhibiting GFP expression (Figure 6.3). 
DNA continued to be distributed ~ 30% in the nuclei and most or all of the rest in 
autophagosomes/autophagolysosomes (Figure 6.8). 
 US was found to be able to deliver pDNA into cell nuclei within 30 min in our 
study and other studies (Duvshani-Eshet and Machluf 2005). This could explain the rapid 
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gene transfection observed within 3 ~ 4 h after US exposure, compared to the kinetics of 
gene transfection mediated by chemical vectors like liposomes, in which it takes ~ 3 
times longer to start seeing gene expression (Mehier-Humbert et al. 2005b). Since the 
protein expression took place after about 3 h once the DNA entered the cell nucleus 
(Mehier-Humbert et al. 2005b), the cells showing early GFP expression probably had 
pDNA in the nuclei shortly after US exposure. Over time, we observed the decrease in 
DNA uptake efficiency possibly due to DNA degradation and cell division. The 
maximum GFP expression was observed at 8 h post US exposure and transfection 
efficiency decreased significantly after 20 h, possibly due to DNA degradation, cell 
division and the limited lifetime of GFP in mammalian cells (Corish and Tyler-Smith 
1999).  
 FCM is generally more sensitive to measure the fraction of cells with pDNA 
uptake, compared to microscopy where uptake cells were counted by naked human eyes. 
This could explain the difference between the uptake efficiency in Figure 6.3a. To get the 
fraction of cell nuclei with pDNA (Figure 6.3b), 3D image analysis was used to quantify 
the colocalization and therefore provided a better method than counting cell nuclei with 
naked human eyes. It also is worth noting that the Cy3/Cy5 labeling process could alter 
pDNA and affect DNA trafficking, localization, uptake and transfection (Gasiorowski 
and Dean 2005). For instance, the fluorophores were randomly attached on the plasmids 
with an alkylating aromatic nitrogen mustard (Belikova et al. 1967) and the bulky 
fluorophores that coat the plasmid may block transcription factors from binding to the 
DNA (Slattum et al. 2003). This could explain the fact that transfection efficiency of 
unlabeled pDNA was higher than labeled pDNA (Figure 6.3c).  
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 It is interesting to see that 30 min post US exposure, pDNA spread out in cells as 
many small red dots under the confocal microscope (Figure 6.2a). After 4h, the red dots 
became less in number and larger in size (Figure 6.2b, c, d), indicating pDNA aggregated 
or were possibly “packaged together”. The histograms showing the fraction of pDNA in 
the nucleus per cell were consistent with these observations (Figure 6.5). At 30 min after 
US exposure, the DNA uptake cells were found with various amount of pDNA in the 
nuclei (Figure 6.5a). At later time points, the DNA uptake cells had most of the pDNA 
either in the cytoplasm or in the nuclei (Figure 6.5d).  
 Although gene transfection mediated by US dose not involve endocytosis (Figure 
6.6), pDNA was found to entrap in large vesicles like autophagosomes and 
autophagolysosomes (Figure 6.7), which were generally thought to originate randomly 
throughout the cytoplasm from the endoplasmic reticulum (Deretic 2005), the post-Golgi 
compartment or the phagophore (Juhasz and Neufeld 2006). Autophagosomes/ 
autophagolysosomes were found to move bidirectionally along microtubules towards and 
away from the cell nuclei with the help of the motor protein dynein (Jahreiss et al. 2008). 
The colocalization of pDNA and autophagosomes/autophagolysosomes was observed as 
early as 30 min after US exposure (Figure 6.7 and 6.8). About 27% of pDNA were 
colocalized with autophagosomes/autophagolysosomes and about 45% of pDNA were 
possibly free in the cytoplasm (Figure 6.8). At 4 h post US exposure, the majority of 
pDNA in the cytoplasm were colocalized with autophagosomes/autophagolysosomes. 
Because naked pDNA could not bind to the adaptor proteins directly, the colocalization 
of pDNA and autophagosomes/autophagolysosomes could possibly facilitate the active 
transport to the cell nuclei, as suggested by some gene therapy studies using other 
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delivery systems (Bukrinskaya et al. 1998; Suomalainen et al. 1999; Vihinen-Ranta et al. 
2000; Ogawa-Goto et al. 2003; Bausinger et al. 2006; Vaughan et al. 2008). The final fate 
of autophagosomes/autophagolysosomes is the same as endosomes/lysosomes. The 
colocalized pDNA could be degraded as their cargo (Eskelinen 2005). As shown in 
Figure 6.8, one day after US exposure, all the pDNA that stayed in the cytoplasm were 
entrapped by autophagosomes/autophagolysosomes. The formation mechanism and 
intracellular itinerary of autophagosomes/autophagolysosomes are not fully clear. Further 
study is needed to better understand how their colocalization with pDNA in US-mediated 
gene transfection affects the exogenous gene trafficking and transfection efficiency. 
 Although further study is needed, these data suggest the following sequence of 
events. Sonication initially delivers DNA into about one third of cells exposed to US. In 
about half of those cells, significant amounts of DNA reach the nucleus within 30 min. 
Overall, approximately one third of DNA that is delivered into cells makes it into the 
nucleus within 4 h and the rest is removed by autophagosomes/autophagolysosomes. 
Over time, the fraction of cells containing DNA decreases to 10% after 24 h. Most of the 
cells that contain DNA in the nucleus express that DNA, which peaks at 8 h after 
sonication.  
 Thus, there are a number of rate-limiting steps to increase DNA transfection by 
US. (i) DNA is delivered into only one third of cells exposed to ultrasound. (ii) Only half 
the cells with intracellular DNA achieve significant DNA levels in the nucleus. (iii) Over 
time, DNA leaves the nucleus and transfection levels drop correspondingly.  
 These observations suggest opportunities to increase DNA transfection by US. (i) 
Increase the fraction of cells that receive intracellular DNA and survive. As shown in the 
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previous chapters, it is difficult to achieve high uptake and high cell viability at the same 
time. Given the known trade-off between increased uptake and cell viability, strategies to 
protect cell viability under conditions that deliver DNA effectively into cells may be 
useful. Some studies have shown the possibility to increased cell viability after US 
exposure by the chelation of intracellular Ca
2+
 and the supplement of ATP energy 
(Schlicher et al. 2006; Hutcheson et al. 2010). (ii) It appears that there is a race between 
DNA transporting to the nucleus before autophagosomes/autophagolysosomes take it 
away. Thus, methods that increase/target DNA trafficking to the nucleus by enhancing 
active transport and methods that decrease clearance by inhibiting autophagosomes/ 
autophagolysosomes may be useful. Microtubule stabilizers (Ogawa-Goto et al. 2003; 
Vaughan and Dean 2006), DNA interchelators (Chu et al. 1987), nuclear localization 
signals (Cartier and Reszka 2002) and DNA targeting sequences have been studies for 
this purpose (Dean et al. 1999). (iii) Loss of DNA from the nucleus may be associated 
with loss of nuclear structural integrity during cell division. Thus, slowly dividing cells in 
the body (as opposed to rapidly dividing cancer cell culture used in this study) may retain 





                                                                                                                           
CHAPTER 7: MICROARRAY STUDY AND DRUG TREATMENT 
COMBINED WITH US EXPOSURE 
 
Introduction 
 The previous chapters have shown that just by optimizing the US exposure 
conditions, we still could not overcome the compromise of cell viability and 
uptake/transfection efficiency, and we also found heterogeneous bioeffects among the 
viable cells, including cells with successful gene transfection, cells with only pDNA 
uptake but no transfection and cells with neither of these bioeffects. In this chapter, we 
were looking for methods other than optimizing the physical parameters of US to 
increase gene transfection.  
  Novel transcriptional profiling technologies such as microarray analysis allow the 
simultaneous measurement of changes in expression of hundreds and thousands of genes. 
It has been used for the characterization of gene expression patterns during diseases and 
normal biological processes, as well as for the identification of specifically expressed 
genes induced by physical and chemical stress (Schena et al. 1995; Cheung et al. 1999; 
Butte 2002). Several studies have utilized this technology for identifying changes in gene 
expression induced by a fairly intense continuous wave (4.9 W/cm
2
 for 1 min) (Schena et 
al. 1995; Tabuchi et al. 2002), focused US (75 W/cm
2
 for 1 min) (Abdollahi et al. 2004), 
continuous high-intensity focused US (6,731 W/cm
2
 for 20 sec) (Hundt et al. 2007), 
short-pulse high-intensity focused US (134 W/cm
2
 for 16.5 min) (Hundt et al. 2007), and 
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low-intensity pulsed US (0.3 W/cm
2
 for 1 min) (Tabuchi et al. 2007). These limited 
expression profile data provided by microarray analysis revealed that US may regulate 
ribosomal proteins expression, influence cell proliferation and differentiation, induce cell 
cycle arrest and apoptosis. These intracellular bioeffects may be cell-type specific and 
US-condition dependent.  
 Unlike these previous studies, we were not investigating the changes in 
transcriptional profile caused by US exposure. We applied microarray technology to 
exploring the differences between sonicated cells with transfection and sonicated cells 
with uptake but no transfection, and looked for biological factors that could increase gene 
transfection efficiency after US exposure. In this present study, gene expression among 
DU145 human prostate cancer cells after US-mediated transfection was analyzed using 
Affymetrix GeneChip
®
 Human Genome U133 Plus 2.0 Arrays. The goal of this study is 
to determine the differences between a cell that takes up DNA after sonication but is not 
transfected and a cell that similarly takes up DNA but is transfected. Our hypothesis is 
that differences in transcriptional profile determined by gene chip analysis will correlated 
with differences in transfection status among cells with DNA uptake. We then seek to use 
this information to identify drugs that mediate the cell’s transcriptional profile to increase 
transfection rates. Stated differently, we seek to learn how to turn cells with DNA uptake 
but no transfection into cells that are transfected by controlling targeted transcriptional 
pathways. We hope these findings can help to better understand the heterogeneous 
bioeffects of US and further suggest additional regulation of intracellular processes to 
enhance gene transfection mediated by US. 
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Results 
Cell Sorting  
 To study the difference between transfection cells expressing GFP and uptake 
cells without the expression of GFP, we first identified and sorted the three populations 
of cells at 8 h after US exposure (Figure 6.1): cells with GFP transfection (green 
fluorescence), cells with labeled pDNA uptake (red fluorescence) and cells with neither 
of these bioeffects. As shown in Figure 7.1, after sorting the purity of each population 
was above 98% (Figure 7.1c, d). 
Gene Chip and Cell Cycle Analysis 
 Affymetrix GeneChip
®
 Human Genome U133 Plus 2.0 Arrays can analyze the 
relative expression level of more than 47,000 transcripts including over 38,500 well-
characterized genes. Transcriptional profiling using these microarrays was performed to 
generally characterize the differences between cells with pDNA uptake and GFP 
expression. 78 genes were found differentially expressed between the two groups of cells, 
32 of which were up-regulated in transfected cells and 46 were down-regulated relative to 
cells with pDNA uptake but lacking expression (Figure 7.2a). The names of these 78 
genes and their fold changes were listed in Appendix B. This result confirmed our 
hypothesis that differences in transcriptional profile correlate with differences in 




Figure 7.1: Representative FCM density plots showing the three populations of 
DU145 cells after incubation for 8 h post US exposure. (a) “sham” exposure before 
sorting; (b) sonicated sample before sorting; (c) cells with pDNA uptake after 
sorting and (d) cells with GFP expression after sorting. Both axes have relative 
units. US exposure conditions: pressure amplitude of 0.78 MPa, total treatment time 
of 1 min with a pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
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(a)                                                                               (b) 
Figure 7.2: Gene expression analysis. (a) The heat map of Z-scores of 78 
differentially expressed genes between the two groups of cells with pDNA uptake 
and GFP expression, sorted by descending  Z-score. The green color indicates 
lower expression and the red indicates higher expression level. (b) The expression 
levels of TOP2α and GADD45α in the two cell populations were determined using 
qRT-PCR. Data represent the means of n = 3 replicates with standard deviation (*p 
< 0.01). Grey bar: cells with pDNA uptake but no transfection. Black bar: cells with 


































The expression levels of two representative genes (TOP2α, Topoisomerase IIα 
and GADD45α, one of the arrest and DNA-damage inducible genes) were measured 
using qRT-PCR to independently test the validity of the differential gene expression 
determined by microarray, because they were two of the most down/up-regulated genes 
(Appendix B). The qRT-PCR results confirmed the differences detected in the microarray 
study (Figure 7.2b, Appendix C). The expression level of TOP2α in transfected cells 
decreased to 30%, while the expression of GADD45α increased by 3 fold, compared to 
cells with pDNA uptake (Figure 7.2b). 
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway (Homo sapiens) 
analysis was applied to the list of genes as shown in Table 7.1. We found that the genes 
involved in cell cycle regulation involved the largest number of genes (8 genes, ~ 10% of 
the total number of the gene list). These 8 genes were mapped to KEGG cell cycle 
pathway (Figure 7.3) and their full names and fold changes were listed in Table 7.2. 
These genes indicated some type of cell cycle arrest present in the transfected cells.   
We then performed cell cycle analysis and found that cells with pDNA uptake and 
cells without bioeffects did not show significant difference in each cell cycle stage. 
However, cells with GFP transfection were found to accumulate in the G1 phase of cell 
cycle compared to the other two populations (Figure 7.4). The promoter of the GFP 
encoding plasmid we used is a constitutively active cytomegalovirus (CMV) promoter, 




Table 7.1: KEGG pathway analysis. 
Enriched terms associated 
with the gene list 
Gene count 
% involved 
genes/total genes  
P-value* 
Cell cycle  8 9.9 2.70E-06 
Progesterone-mediated oocyte 
maturation 
5 6.2 9.90E-04 
Oocyte meiosis  5 6.2 2.50E-03 
Pathogenic Escherichia coli 
infection 
3 3.7 3.60E-02 
p53 signaling pathway 3 3.7 5.00E-02 
Gap junction 3 3.7 8.00E-02 
*Modified Fisher Exact p-value, EASE Score. The smaller, the more enriched. 
 
Table 7.2: KEGG cell cycle enriched genes by PATHWAY EXPRESS (Bonferroni 





Gene Symbol Gene Name Fold Change
BUB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast)-3.80
SKP2 S-phase kinase-associated protein 2 (p45) -3.40
CDC2 cell division cycle 2, G1 to S and G2 to M -3.20
BUB1 BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) -2.90
MAD2L1 MAD2 mitotic arrest deficient-like 1 (yeast) -2.60
CCNB1 cyclin B1 -2.50
CCNA2 cyclin A2 -2.40
GADD45A growth arrest and DNA-damage-inducible, alpha 3.10
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Figure 7.3: Pathway Express rendering of enriched genes on KEGG Cell Cycle 
Pathway Map. Each box represents a particular gene. The blue color represents 
down-regulated genes and the red represents up-regulated genes in cells with GFP 
expression relative to cells with pDNA uptake. 
 
Both the cell cycle and microarray analysis indicated cell cycle arrest in the cells 
with gene transfection. Among all the genes of interest, TOP2α and GADD45α were 
chosen for further study because they were two of the most down/up-regulated genes and 
they were both involved in cell cycle regulation. GADD45α is one of the growth arrest 
and DNA-damage inducible genes. It is a p53-regulated gene as shown in the KEGG cell 
cycle pathway analysis (Figure 7.3) (Kastan et al. 1992). The expression level of 
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GADD45 has been found to be associated with cell cycle, being the maximal in G1 phase 
(Kearsey et al. 1995). Overexpression of GADD45α in vitro retarded cell growth and 
increased accumulation in G1 phase or G2/M boundary of cell cycle (Fan et al. 1999; 
Harkin et al. 1999; Wang et al. 1999; Liebermann and Hoffman 2008). It is hypothesized 
that the interaction of GADD45 with p21, another p53-regulated gene (Figure 7.3), leads 
to G1 phase arrest, although the mechanism is not well understood (Kearsey et al. 1995). 
 
Figure 7.4:  Cell cycle analysis of the three populations at 8 h post US exposure: cells 
without bioeffects (white bar), cells with pDNA uptake (grey bar) and cells with 
GFP transfection (black bar). Data represent the averages of n ≥ 3 replicates with 
standard deviation (*p < 0.05). US exposure conditions: pressure amplitude of 0.78 
MPa, total treatment time of 1 min with a pulse length of 0.25 ms at a duty cycle of 
25%, Definity
®






























Topoisomerase II is a dimeric enzyme involved in altering DNA topology 
(Champoux 2001). TOP2α isoform is necessary for chromosome condensation and 
segregation in mitosis. The concentration of TOP2β isoform is relatively constant over 
cell cycle, while the expression of TOP2α is coupled with cell cycle. The level of TOP2α 
protein synthesis is significantly higher in the late S and G2/M phase than during G1 
phase (Goswami et al. 1996). That is, TOP2α is down-regulated in the G1 phase of cell 
cycle. Our results found its expression level decreased in GFP-expressing cells together 
with increased expression level of GADD45α. The down-regulation of TOP2α and up-
regulation of GADD45α in GFP-expressing cells were consistent with our cell cycle 
analysis, which indicated that cells with GFP transfection accumulated in the G1 phase of 
cell cycle.   
Drug Treatment Combined with US Exposure 
 Three strategies were proposed to further enhance US-mediated gene transfection 
in DU145 cells: inhibiting the expression of TOP2α, enhancing the overexpression of 
GADD45α, and regulating the active transport and trafficking in the cytoplasm. We then 
selected drugs that regulate these intracellular processes, combined drug treatment with 
US exposure, and analyzed the bioeffects including gene transfection efficiency, DNA 
uptake efficiency and cell viability. Considering the possible additional damage to the 
cell integrity caused by the drug treatment, we determined the transfection efficiency in 
the cells remaining viable after 8-h incubation post US exposure and also the transfection 
efficiency in all the cells by comparing the number of cells in the sonication samples with 
that in the “sham” controls. 
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Drugs that Induce GADD45α Expression 
 Ethyl methanesulfomate (EMS), N-methyl-D-Aspartate (NMDA) and PRIMA-1 
(p53 reactivation and induction of massive apoptosis) were chosen to enhance the 
expression of GADD45α because they were suggested to induce the overexpression of 
GADD45α via different mechanisms.  
EMS 
 The expression level of GADD45α was previously found to be increased by 1 ~ 5 
fold in cultured cells by the exposure to alkylating agents such as EMS (Papathanasiou et 
al. 1991). The ethyl group of EMS reacts with guanine in DNA, induces DNA damage 
and therefore causes the overexpression of GADD45α. In this study, EMS was added to 
the cell sample at a final concentration of 0.6 or 3 mg/mL for US exposure. With EMS 
treatment, the transfection efficiency was increased by 2 fold, while the cell viability was 
not affected compared to US exposure alone (Figure 7.5). The effect of different 









































































Figure 7.5: EMS treatment increased the transfection efficiency mediated by US 
without affecting the cell viability. Data represent the averages of n ≥ 3 replicates 
with standard deviation (*paired Student’s t-test, p < 0.01). US conditions: pressure 
amplitude of 0.78 MPa, total treatment time of 1 min with a pulse length of 0.25 ms 
at a duty cycle of 25%, Definity
®
 concentration of 1 vol%. 
 
NMDA 
 NMDA is a known excitotoxin and has been shown to increase the expression 
level of GADD45α in neuronal cells (Laabich et al. 2001; Uberti et al. 2002). NMDA-
induced GADD45α expression generally requires the activation of NMDA receptors 
(Uberti et al. 2002). Treating DU145 cells with NMDA for US exposure, we found the 
transfection efficiency in live cells was increased by 12%, while the cell viability was 
decreased compared to US exposure alone. The overall transfection efficiency among all 
the cells was not changed (Figure 7.6). 
 
 
Figure 7.6: NMDA treatment (2 mM) increased the transfection efficiency mediated 
by US in live cells, but decreased the cell viability. Data represent the averages of n 





































































conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min with a 
pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
 concentration of 1 vol%. 
 
PRIMA-1 
 PRIMA-1 was previously found to reactivate mutant p53 (Kastan et al. 1992; 
Lambert et al. 2009), which was supposed to up-regulate the expression level of 
GADD45α (Figure 7.3). We treated DU145 cells with up to 1 mM PRIMA-1 for US 
exposure and did not find any enhancement in gene transfection (Figure 7.7). A possible 
reason is that the regulation of GADD45α was not direct but through reactivating p53 in 




Figure 7.7: PRIMA-1 treatment (1 mM) did not affect the transfection efficiency 
mediated by US but decreased the cell viability. Data represent the averages of n ≥ 3 
replicates with standard deviation (*paired Student’s t-test, p < 0.05). US 
conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min with a 
pulse length of 0.25 ms at a duty cycle of 25%, Definity
®





































































Drugs that Inhibit TOP2α Expression 
 There are several kinds of TOP2α inhibitors based on the action mechanisms of 
eukaryotic TOP2 (Sehested and Jensen 1996; Burden and Osheroff 1998). In the present 
study, chloroquine, aclarubicin, amsacrine, mitoxantrone and etoposide were tested. 
Chloroquine and aclarubicin were two representative catalytic inhibitors of TOP2α by 
inhibiting the enzyme in binding to its substrate DNA (Andoh and Ishida 1998). 
Amsacrine, mitoxantrone and etoposide were representative TOP2α poisons that stabilize 
the structure of the DNA/TOP2 complex and so that the closure of TOP2-catalyzed DNA 
break is not possible (Nelson et al. 1984).  
Amsacrine Hydrochloride 
 Amsacrine can poison TOP2α by stabilizing the structure of the DNA/TOP2 
complex and so that the reaction cannot move forward (Nelson et al. 1984). When 
amsacrine was added to the cell samples for US exposure, the transfection efficiency was 
increased by ~ 50%. Although the cell viability was decreased, the overall transfection 
efficiency among all the cells was increased (Figure 7.8). 
Chloroquine Diphosphate Salt 
 Chloroquine is a DNA interchalater that inhibits TOP2α by preventing this 
enzyme from binding to its substrate DNA (Andoh and Ishida 1998). When we treated 
cells with chloroquine for US exposure, the transfection efficiency was found increased 





Figure 7.8: Amsacrine treatment (200 nM) increased the transfection efficiency 
mediated by US and decreased the cell viability. Data represent the averages of n ≥ 3 
replicates with standard deviation (*paired Student’s t-test, p < 0.05). US 
conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min with a 
pulse length of 0.25 ms at a duty cycle of 25%, Definity
®




Figure 7.9: Chloroquine treatment (100 µM) increased the transfection efficiency 






































































































































≥ 3 replicates with standard deviation (*paired Student’s t-test, p < 0.05). US 
conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min with a 
pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
 concentration of 1 vol%. 
 
 Chloroquine is not only a TOP2α inhibitor but also a DNA interchalater (Luthman 
and Magnusson 1983; Sehested and Jensen 1996; Snyder 2000). As a weak organic base, 
chloroquine can neutralize the pH of endosomes/lysosomes and autophagosomes/ 
autophagolysosomes, and therefore possibly prevent DNA degradation (Maxfield 1982; 
Dijkstra et al. 1984; Erbacher et al. 1996). We previously observed the colocalization of 
pDNA with LysoTracker
®
-labeled autophagosomes/autophagolysosomes (Figure 6.7). To 
test whether chloroquine affected endosomes/lysosomes and autophagosomes/ 
autophagolysosomes, we measured the geometric mean of the green fluorescence 
indicating LysoTracker
®
-labeled endosomes/lysosomes and autophagosomes/ 
autophagolysosomes after US exposure with or without chloroquine treatment. As shown 
in Figure 7.10, the peak of the green fluorescence with chloroquine treatment shifted to 
the left compared to that without chloroquine treatment, indicating a less strong 
fluorescence of LysoTracker
®
-labeled endosomes/lysosomes and autophagosomes/ 
autophagolysosomes with chloroquine treatment. Therefore, it appears that chloroquine 




                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
Figure 7.10: A representative FCM histogram showing the geometric mean of green 
fluorescence among sonicated cells after LysoTracker
®
 staining decreased by an 
average of 24% (n = 6, paired Student’s t-test p = 0.01) with chloroquine treatment. 
US conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min with a 
pulse length of 0.25 ms at a duty cycle of 25%, Definity
®




 Similar like amsacrine, etoposide is also a TOP2α poison that can stabilize the 
structure of the DNA/TOP2 complex and cause DNA double-strand break (Liu 1989). 
Treating cells with etoposide for US exposure did not further increase gene transfection 
efficiency but decreased the cell viability (Figure 7.11). 
 
1 – US with chloroquine





Figure 7.11: Etoposide treatment (200 nM) did not affect the transfection efficiency 
mediated by US but decreased the cell viability. Data represent the averages of n ≥ 3 
replicates with standard deviation (*paired Student’s t-test, p < 0.05). US 
conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min with a 
pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
 concentration of 1 vol%. 
 
Mitoxantrone dihydrochloride 
 Mitoxantrone is another TOP2α poison. DU145 human prostate cancer cells were 
found to be relatively insensitive to certain TOP2 poisons including etoposide and 
mitoxantrone (Salido et al. 1999; van Brussel et al. 1999), which could explain the fact 
that at the concentrations we tested, no further enhancement of gene transfection was 






































































Figure 7.12: Mitoxantrone treatment (200 nM) did not affect the transfection 
efficiency mediated by US but decreased the cell viability. Data represent the 
averages of n ≥ 3 replicates with standard deviation (*paired Student’s t-test, p < 
0.05). US conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min 
with a pulse length of 0.25 ms at a duty cycle of 25%, Definity
®




 Aclarubicin is another catalytic inhibitor of TOP2α by inhibiting the enzyme in 
binding to its substrate DNA (Andoh and Ishida 1998). Treating DU145 cells with 
aclarubicin for US exposure did not increase gene transfection efficiency while cell 






































































Figure 7.13: Aclarubicin treatment (50 nM) did not affect the transfection efficiency 
mediated by US but decreased the cell viability. Data represent the averages of n ≥ 3 
replicates with standard deviation (*paired Student’s t-test, p < 0.05). US 
conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min with a 
pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
 concentration of 1 vol%. 
 
Expressional Regulation of TOP2α and GADD45α 
 To test whether the above four drugs that increased gene transfection efficiency 
regulated the expression level of TOP2α or GADD45α in DU145 cells, cells were 
sonicated with 100 µM chloroquine, 200 nM amsacrine, 0.6 mg/mL EMS, or 2 mM 
NMDA, separately, and incubated at growth conditions for 8 h. The results of qRT-PCR 
showed that in cells treated with EMS or NMDA, the expression level of GADD45α was 
found to be increased by 3 and 1.2 fold, respectively. The treatment with chloroquine 
decreased the expression level of TOP2α by 43%, and amsacrine decreased the 




































































that EMS and NMDA enhanced the overexpression of GADD45α, and chloroquine and 
amsacrine inhibited the expression of TOP2α in DU145 cells.  
 
 
Figure 7.14: Results from qRT-PCR confirmed that the treatment with EMS or 
NMDA increased the expression level of GADD45α (grey bars), and the treatment 
with chloroquine or amsacrine decreased the expression level of TOP2α (black 
bars). Data represent the averages of n = 3 replicates with standard deviation (p < 
0.05). US conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min 
with a pulse length of 0.25 ms at a duty cycle of 25%, Definity
®






































Drugs that Regulate Active Transport and Trafficking 
 The regulation of DNA trafficking by enhancing active transport or inhibiting 
lysosomes-associated degradation to increase transfection efficiency was previously 
studied using gene delivery systems like electroporation and chemical vectors (Luthman 
and Magnusson 1983; Vaughan et al. 2008). Whether these regulations also facilitate US-
mediated gene transfection is of interest. Therefore, in addition to the regulation of the 
expression levels of TOP2α and GADD45α, we also selected drugs that were found to 
enhance or suppress the active transport and trafficking in the cytoplasm and tested their 




) is an anti-tumor drug that is known to stabilize microtubules 
and thereby prevent cancer cells from division (Horwitz 1994). Some gene delivery 
vectors including viral and chemical vectors were previously verified to utilize 
microtubules to reach the nucleus (Bukrinskaya et al. 1998; Suomalainen et al. 1999; 
Vihinen-Ranta et al. 2000; Ogawa-Goto et al. 2003; Bausinger et al. 2006). It is 
suggested that plasmid DNA may also utilize microtubules to transport from the cell 
membrane to the nucleus in other physical gene delivery systems. Stabilizing 
microtubules was found to increase gene transfection efficiency using electroporation and 
microinjection (Vaughan and Dean 2006).  In our study, when cells were sonicated with 
paclitaxel, transfection efficiency in live cells was increased by ~ 27%. However, cell 
viability was decreased by 24% compared to US exposure alone. Because of the further 
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decrease in cell viability caused by paclitaxel, the overall transfection efficiency among 
all the cells was not affected compared to US exposure alone (Figure 7.15).  
 
 
Figure 7.15: Paclitaxel treatment (16 µM) increased the transfection efficiency in 
live cells but decreased the cell viability. Data represent the averages of n ≥ 3 
replicates with standard deviation (*paired Student’s t-test, p < 0.05). US 
conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min with a 
pulse length of 0.25 ms at a duty cycle of 25%, Definity
®





) is an analog of paclitaxel. It was demonstrated to have 
higher affinity for microtubules and thereby stronger cytotoxicity to cancer cells (Pazdur 
et al. 1993). With docetaxel treatment, the transfection efficiency was increased by 30% 
in live cells, but the cell viability was decreased by 36% compared to US exposure alone. 
The overall transfection efficiency among all the cells was decreased because of the 







































































Figure 7.16: Docetaxel treatment (16 µM) increased the transfection efficiency in 
live cells but decreased the cell viability.  Data represent the averages of n ≥ 3 
replicates with standard deviation (*paired Student’s t-test, p < 0.05). US 
conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min with a 
pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
 concentration of 1 vol%. 
 
Tetracaine Hydrochloride 
 We found that enhancing active transport using microtubule stabilizing drugs 
(paclitaxel and docetaxel) could increase transfection efficiency in live cells post US 
exposure, but cause further damage to cell viability. We were also interested to test if 
inhibiting transport in the cytoplasm could cause any decrease in gene transfection 
efficiency. Tetracaine is a local anesthetic that is able to suppress the movement of motor 
proteins and thereby inhibit the active transport along the cytoskeleton (Ayad and White 
1977; Miyamoto et al. 2000). When tetracaine was added to the cell samples for US 





































































DU145 cells was not affected (Figure 7.17). This result indicated that inhibiting active 
transport in cells could decrease gene transfection efficiency after US exposure. 
 
 
Figure 7.17: Tetracaine treatment (20 µM) decreased the transfection efficiency 
mediated by US without affecting the cell viability.  Data represent the averages of n 
≥ 3 replicates with standard deviation (*paired Student’s t-test, p < 0.05). US 
conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min with a 
pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
 concentration of 2 vol%. 
 
Bafilomycin A1 
 Bafilomycin A1 was previously found to be able to prevent maturation of 
autophagic vacuoles (Yamamoto et al. 1998), and therefore might be able to prevent 
pDNA from degradation. However, when adding 250 nM bafilomycin A1 to the 
sonication sample, we did not observe any increase in gene transfection efficiency but 






































































Figure 7.18: Bafilomycin A1 (250 nM) did not affect the transfection efficiency 
mediated by US but decreased the cell viability.  Data represent the averages of n ≥ 
3 replicates with standard deviation (*paired Student’s t-test, p < 0.05). US 
conditions: pressure amplitude of 0.78 MPa, total treatment time of 1 min with a 
pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
 concentration of 1 vol%. 
 
Uptake Efficiency with Drug Treatment 
 So far we have found the several drugs could enhance gene transfection mediated 
by US and hypothesized that they acted by influencing DNA trafficking within the cell, 
as opposed to affecting DNA uptake into the cell. We therefore also tested whether 
adding these drugs could affect the uptake efficiency of pDNA in DU145 cells. As shown 
in Figure 7.19, the DNA uptake efficiency mediated by US exposure was not affected by 






































































Figure 7.19: Fold change of US-mediated DNA uptake with and without drug 
treatment of 0.6 mg/mL EMS, 2 mM NMDA, 200 nM amsacrine, 100 µM 
chloroquine, 16 µM paclitaxel, or 16 µM docetaxel. Data represent the averages of n 
= 3 replicates and the error bars represent 95% confidence interval (Student’s t-
test, p > 0.05). US conditions: pressure amplitude of 0.78 MPa, total treatment time 
of 1 min with a pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
 
concentration of 1 vol%. 
 
Treatment with the Regulation of both TOP2α and GADD45α 
 Previously we found EMS and NMDA increased transfection efficiency post US 
exposure by inducing the overexpression of GADD45α, and amsacrine and chloroquine 
enhanced gene transfection mediated by US by inhibiting the expression of TOP2α in 
DU145 cells. We then regulated the expression levels of GADD45α and TOP2α at the 
same time and tested the bioeffects on gene transfection. 





























 Combine EMS and amsacrine treatment with US exposure, and we increased gene 
transfection efficiency by ~ 30% without affecting the cell viability (Figure 7.20). 
 
 
Figure 7.20: Drug treatment with 0.6 mg/mL EMS and 200 nM amsacrine increased 
the transfection efficiency mediated by US without affecting the cell viability. Data 
represent the averages of n ≥ 3 replicates with standard deviation (*paired Student’s 
t-test, p < 0.05). US conditions: pressure amplitude of 0.78 MPa, total treatment 
time of 1 min with a pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
 
concentration of 1 vol%. 
 
EMS and Chloroquine  
 When cells were treated with both EMS and chloroquine for US exposure, gene 









































































Figure 7.21: Drug treatment with 0.6 mg/mL EMS and 100 µM chloroquine 
increased the transfection efficiency mediated by US without affecting the cell 
viability. Data represent the averages of n ≥ 3 replicates with standard deviation 
(*paired Student’s t-test, p < 0.05). US conditions: pressure amplitude of 0.78 MPa, 
total treatment time of 1 min with a pulse length of 0.25 ms at a duty cycle of 25%, 
Definity
®
 concentration of 1 vol%. 
 
NMDA and Amsacrine  
 Combine NMDA and amsacrine treatment with US exposure, and we increased 
gene transfection efficiency in DU145 cells by ~ 50%. The cell viability was decreased 
by ~ 10%, but the overall transfection efficiency among all the cells was increased 









































































Figure 7.22: Drug treatment with 2 mM NMDA and 200 nM amsacrine increased 
the transfection efficiency mediated by US but decreased the cell viability. Data 
represent the averages of n ≥ 3 replicates with standard deviation (*paired Student’s 
t-test, p < 0.05). US conditions: pressure amplitude of 0.78 MPa, total treatment 
time of 1 min with a pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
 
concentration of 1 vol%. 
 
NMDA and Chloroquine  
 When cells were treated with both NMDA and chloroquine for US exposure, gene 
transfection efficiency in live cells was increased by ~ 20% and the cell viability was 
decreased by ~ 10%. The overall transfection efficiency among all the cells was not 








































































Figure 7.23: Drug treatment with 2 mM NMDA and 100 µM chloroquine increased 
the transfection efficiency mediated by US but decreased the cell viability. Data 
represent the averages of n ≥ 3 replicates with standard deviation (*paired Student’s 
t-test, p < 0.05). US conditions: pressure amplitude of 0.78 MPa, total treatment 
time of 1 min with a pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
 
concentration of 1 vol%. 
 
Summarized Results of Drug Treatment 
 A summary of our findings from the drug treatment combined with US exposure 
is shown in Figure 7.24 and Appendix D. We found treating cells with EMS, NMDA, 
Amsacrine, chloroquine, paclitaxel and docetaxel increased transfection efficiency in live 
cells mediated by US exposure (Figure 7.24a). The overall transfection efficiency among 
all the cells was dependent on cell viability. EMS and chloroquine did not affect the cell 
viability, while NMDA, amsacrine, paclitaxel and docetaxel caused damage to the cell 
viability (Appendix D). Therefore, the transfection efficiency among all the cells was not 
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Figure 7.24: The fold change of gene transfection efficiency in (a) live cells and (b) 
all cells with drug treatment compared to that without drug treatment. Data 
represent the averages of n ≥ 3 replicates. The error bars represent 95% confidence 
interval (*Student’s t-test p < 0.05, compared to no drug treatment). The 
concentration used for each drug: 0.6 mg/mL EMS, 2 mM NMDA, 1 mM PRIMA-1, 
200 nM amsacrine, 100 µM chloroquine, 200 nM etoposide, 200 nM mitoxantrone, 
50 nM aclarubicin, 16 µM paclitaxel, 16 µM docetaxel, 20 µM tetracaine and 250 
nM bafilomycin A1. US conditions: pressure amplitude of 0.78 MPa, total treatment 
time of 1 min with a pulse length of 0.25 ms at a duty cycle of 25%, Definity
®
 
concentration of 1 vol%. 
 
 Under the conditions we have tested, PRIMA-1, etoposide, mitoxantrone, 
aclarubicin and bafilomycin A1 did not affect gene transfection mediated by US (Figure 
7.24), but decreased the cell viability (Appendix D). Suppressing active transport by 
tetracaine decreased transfection efficiency (Figure 7.24) without affecting the cell 
viability (Appendix D). Combine the treatment to regulate the expression levels of 
TOP2α and GADD45α at the same time, and we found US-mediated gene transfection 
was enhanced compared to US exposure alone. The enhancement in transfection with two 
drugs was not significantly different from that with one drug (Figure 7.24).  
 
Discussion 
The heterogeneous bioeffects caused by US may be one of the major reasons 
responsible for the low gene transfection efficiency. US exposure generates various 
populations of dead cells, live cells with pDNA uptake, live cells with successful gene 
transfection, and live cells with neither of the two bioeffects. In this study, we transfected 
DU145 cells with GFP encoded pDNA using 1 MHz US, and analyzed gene expression 
in cells with GFP expression and cells with pDNA uptake but no GFP expression using 
microarray. Genes related to cell cycle were found to play an important role in US-
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mediated gene transfection. Cells with successful GFP expression were found to be 
associated with cell cycle regulation, which is consistent with the independent cell cycle 
analysis. These findings suggested that slowing down cell cycle was good for gene 
transfection mediated by US. This would possibly favor the in vivo application of US for 
gene therapy, because cells packed in tissues generally have slow cell cycle. 
Among all the genes of interest, GADD45α and TOP2α were chosen for further 
study because they were two of the most up/down-regulated genes and they were both 
related to cell cycle regulation. We proposed three strategies to enhance US-mediated 
gene transfection by up-regulating GADD45α, down-regulating TOP2α, and enhacing or 
surpressing active transport and trafficking in the cytoplasm. Several drugs were selected 
according to these strategies to test the bioeffects combined with US exposure. 
In the previous chapter we reported that under the optimal US conditions, the 
maximum pDNA uptake was ~ 30% right after US exposure, while the maximum 
transfection efficiency was ~ 12% observed at 8 h post US exposure (Figure 6.3). In this 
study, combine US exposure and the treatment with 0.6 mg/mL EMS and 100 µM 
chloroquine, or EMS alone, and we further increased transfection efficiency by ~ 2 fold. 
These results indicated that combining drug treatment with US exposure, we could 
possibly increase gene transfection efficiency as high as close to the DNA uptake 
efficiency. Using microtubule stablilizers for US exposure also enhanced gene 
transfection, and inhibiting active tranport by tetracaine decreased gene transfection 
efficiency. These results indicated that possible active transport of DNA was happening 
in cells post US exposure. Facilitating active tranport could potentially enhance gene 
transfection mediated by US. 
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It is already known that different cell lines respond differently to either US 
exposure (Larina et al. 2005) or drug treatment (Fry et al. 1991; Schatten et al. 2000; 
Lanzi et al. 2001). One cell line also responds differently to similar drugs that are 
expected to have the same effects. In this study, we used DU145, an androgen-insensitive 
prostate cancer cell line that generally expresses high level of TOP2α (Pourpak et al. 
2007). Since the cellular TOP2α level is related to chemosensitivity to certain TOP2α 
inhibitors (Fry et al. 1991; Asano et al. 1996; Burden and Osheroff 1998; Bronner et al. 
2002), DU145 cells are relatively insensitive to certain TOP2 poisons like etoposide and 
mitoxantrone (Salido et al. 1999; van Brussel et al. 1999). These factors may contribute 
to our results that chloroquine and amsacrine enhanced US-mediated gene transfection, 
while mitoxantrone or etoposide did not show similar effects. Both chloroquine and 
aclarubicin are catalytic inhibitors of TOP2α. However, in our study, cells reacted 
differenctly to these two drugs. The treatment with 100 µM chloroquine enhanced gene 
transfection mediated by US exposure without casuing further damage to the cell viability, 
while 50 nM aclarubicin decreased the viability of DU145 cells by ~ 20% compared to 
US exposure alone, but did not affect gene transfection. 
Most of these drugs we have tested are anti-tumor durgs, which are able to 
regulate cell cycle, induce apoptosis or necrosis and kill cancer cells. Therefore, the 
viability of DU145 cells was likely affected, and that may or may not be a wanted effect 
depending on the purpose of gene therapy. Some of these drugs have multiple functions 
and may affect gene transfection through multiple mechanisms. For example, chloroquine 
is a catalytic inhibitor of TOP2 and also a DNA interchalator that could prevent pDNA 
from degradation (Luthman and Magnusson 1983). Etoposide as a TOP2 poison was also 
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tested on its function to enhance GADD45α as a DNA-damaging agent, however, those 
studies indicated that etoposide treatment had some but limited capability of inducing 
GADD45α expression (West et al. 2002; Li et al. 2009). 
Since the drugs we have tested are mostly toxic to DU145 cells, we chose to add 
them to the concentrated cell suspension, perform US and incubate cells at the growth 
conditions for 8 h with a much lower concentration of drugs (a dilution of 50 times). In 
this way, we expected to have efficient delivery of these drugs in cells and reduce harm 
to cells. To optimize the effects of drug treatment, more detailed studies may be designed 
to investigate the time of adding these drugs (before or after US exposure) and the  
overall treatment time. It is also possible that changing drug concentration could result in 
different effects on cell viability and gene transfection, although higher concentration of 
EMS in our study did not show any difference from the lower concentration treatment. 
Other methods to regulate gene expression, such as siRNA, could also be tested. While 
the specific drugs examined in this study may be useful directly for possible US-based 
gene transfection, the greater value of this study may be identification of bottlenecks to 
DNA delivery, which suggest additional strategies that do no involve toxic 
chemotherapeutics, such as employing siRNA to modulcate TOP2α, GADD45α and other 
protein expression, nuclear localization sequences to direct DNA trafficking to the 
nucleus, cell cycle modulation by various other means and strategies. 
Gene transfection efficiency was found to be dependent on cell cycle in some 
chemical non-viral delivery systems (Mortimer et al. 1999; Brunner et al. 2000). This is 
the first time when the cell cycle dependency of transfection efficiecy was studied with 
US as a gene delivery strategy. The fact that GADD45α was overexpressed and TOP2α 
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was down-regulated in the cells with successful gene transfection, which accumulated at 
the G1 phase of cell cycle, may offer new clues for the better understanding of the 
mechanism of US-mediated gene transfection. We verified in this study that by regulating 
the expression level of GADD45α and TOP2α and other intracellular processes, higher 
efficiency of US-mediated gene transfection could be achieved. 
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CHAPTER 8: THE INTEGRITY OF GENE DELIVERY CARRIERS 
 
Introduction 
 Although US has been widely used in clinics, safety is a concern when designing 
US systems for drug delivery and gene transfection. In this part of the study, a broad 
range of US conditions were tested to evaluate the possibility that US exposure can 
adversely affect the integrity and, therefore, the bioactivity of various therapeutic agents. 
We carried out studies to examine the effects of US on the integrity of plasmid DNA, 
siRNA and a viral vector. We selected these models because they are of interest to gene-
based therapies and might be more sensitive to damage by US. Possible damage to 
neuronal cells by US exposure was also examined. The results indicated that US itself did 
not affect the integrity of gene delivery carriers and cell viability over the range of US 
conditions tested. US may offer a safe treatment strategy for gene transfection.  
Results 
 To assess whether US damages DNA, we exposed plasmid DNA encoding GFP 
to US over energy densities ranging from 0 to 12,000 J/cm
2
. We selected this range of US 
conditions because it included and well exceeded those found to be useful for enhanced 
delivery in vitro and in vivo in the previous sections. After sonication, the DNA was 
transfected into cultured cells using a lipid transfection agent as an assessment of DNA 
integrity. There was no significant difference in transfection efficiency between DNA 
sonicated at any of the conditions tested compared to non-sonicated controls (p > 0.05) as 
shown in Figure 8.1a. Note that sonication was not used in this study to aid DNA entry 
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into cells, as has been shown in the previous chapters. The goal of this safety study was 
to determine if sonication damaged DNA in some way that affected subsequent 
transfection of cells. 
 
Figure 8.1: Effect of US exposure on plasmid DNA, siRNA, and virus integrity and 
cortical neuron viability. (a) Plasmid gWizTM-GFP and (b) survivin-siRNA were 
sonicated and subsequently transfected to DU145 cells by Lipofectamine 2000. Each 
bar displays the average and standard deviation of (a) the transfection efficiency 
normalized by the non-sonicated control DNA and (b) the survivin knockdown 
efficiency normalized by the non-sonicated siRNA (n ≥ 4 replicates). Percent 
survivin knockdown was determined based on survivin expression levels from cells 
without siRNA transfection set equal to 0% protein knockdown. Student’s t-test 
showed no significant changes in (a) transfection efficiency and (b) knockdown 
efficiency at any of the conditions tested relative to the non-sonicated control (p > 
0.05). (c) Adeno-associated virus was sonicated and subsequently transduced to HT-
1080 cells. Each bar displays the average and standard deviation of the transduction 
efficiency normalized by non-sonicated control virus (n ≥ 4 replicates). Student’s t-
test showed no significant changes in transduction efficiency at any of the conditions 
tested relative to the non-sonicated control (p > 0.05). (d) Cortical neurons were 
sonicated at different US conditions and, in one case, in the presence of Definity
®
 US 







































































































































































































































viability normalized by non-sonicated control neurons (n ≥ 4 replicates). Student’s t-
test showed no significant changes in cell viability at any of the conditions tested 
relative to the non-sonicated control (p > 0.05), except at the conditions indicated: 
(*) p = 0.016, (**) p = 0.0013, (***) p = 0.0006.  
 
 A similar experiment was carried out to assess the effects of US on the ability of 
siRNA to knock down expression of a model protein, survivin. As shown in Figure 8.1b, 
there were no significant differences in the level of protein knockdown between siRNA 
sonicated at any of the conditions tested compared to non-sonicated controls (p > 0.05).  
 The effects of US on function of an adeno-associated virus are shown in Figure 
8.1c. Over the range of conditions examined, there were no significant differences in the 
level of transduction efficiency between sonicated adeno-associated virus and non-
sonicated controls (p > 0.05), indicating the integrity of virus was not affected by US. 
 Finally, the effect of US on the viability of cortical neurons freshly harvested 
from fetal rats was examined. As shown in Figure 8.1d, sonication at pressures up to 1.5 
MPa for up to 60 min (energy density 6,750 J/cm
2
) had no significant effect on neuronal 
cell viability (p > 0.05), which is consistent with the previous histology study. However, 
cell viability was decreased when the acoustic pressure was increased to the highest 
energy density of 12,000 J/cm
2
, which caused cell viability to decrease by 19% (p = 
0.0013). As a positive control, sonication was carried out at 2,000 J/cm
2
 in the presence 
of Definity
®
 US contrast agent, which served to nucleate cavitation activity. Under these 
conditions, cell viability was reduced by 35% (p = 0.0006). However, the conditions that 
caused losses of cell viability are much stronger than the ones found to be useful for gene 




 This study provided an initial assessment of the safety of US exposure for gene 
delivery. Because of its non-invasive nature, US has the potential to avoid tissue damage. 
This expected safety, under other US conditions, is well established for clinical use of US 
for diagnostic imaging and therapeutic heating (Fowlkes and Holland 2000). In this 
study, exposure of US was found to be well tolerated by cultured cortical neurons in 
vitro. Specifically, viability of cortical neurons was unaffected over most US conditions. 
Sonication at the highest energy density of 12,000 J/cm
2
 significantly reduced cell 
viability; however, this energy level was well beyond the minimum conditions found to 
be effective for enhanced delivery. 
 As a secondary objective, we evaluated the potency of US not only to facilitate 
gene transfection but also to preserve the biological activity of the gene carriers delivered 
by it. The sonochemical effects of US such as production of free radicals during 
cavitation events have been demonstrated to change the activity of drugs (Rosenthal et al. 
2004). We carried out experiments designed to assess the functionality of several 
therapeutic biomolecules of interest after US treatment. This study showed that exposure 
to US at any of the conditions tested did not significantly affect transfection efficiency of 
the plasmid DNA, protein knockdown efficiency of the siRNA, or transduction efficiency 
of the adeno-associated virus. These studies suggest that there is a broad range of US 
conditions that may be suitable for enhanced gene transfection without damaging the 
integrity of plasmid DNA, siRNA, adeno-associated virus or cortical neurons. Additional 
in vivo studies will be needed, which eliminate the artifacts of in vitro cells in suspension, 
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such as increased shear stress due to acoustic streaming and cavitational activity, and the 





CHAPTER 9: DISCUSSION AND CONCLUSIONS 
 
 US-mediated gene transfection is of interest among the current gene delivery 
systems due to its unique expected advantages, including: low toxicity, low 
immunogenicity, the potential for repeated application, organ specificity and broad 
applicability to acoustically accessible organs (Gao et al. 2007). However, the major 
problem in US-mediated gene transfection is the low transfection efficiency. In vitro US 
exposure generates various populations of dead cells, live cells with pDNA uptake, live 
cells with successful gene transfection, and live cells with neither of the two bioeffects. In 
this study, we transfected DU145 cells with GFP encoded pDNA using 1 MHz US. We 
studied the compromise of cell viability and uptake efficiency; optimized the US 
conditions for gene transfection; evaluated the capability of US to deliver DNA to the cell 
nuclei, which is critical to achieve successful transfection; investigated the differences 
between DNA uptake cells and gene transfection cells; and verified the possibility to 
further increase transfection efficiency by combining US exposure with drug treatment 
that regulates intracellular processes. 
 Various US apparatus systems have been designed and a variety of US exposure 
conditions (e.g., frequency, energy intensity, pulse length, acoustic pressure) have been 
tested previously on different types of cells and tissues both in vitro and in vivo to 
facilitate drug/gene delivery (Mitragotri 2005). Although the bioeffects caused by US 
exposure was found to differ due to the US conditions and cell/tissue types, nearly all the 
studies reported the compromise of cell viability and uptake/transfection efficiency, that 
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is, high uptake/transfection efficiency was often associated with low cell viability. We 
found, in this study, changing the US contrast agents or increasing the sonication 
temperature could possibly increase the uptake efficiency without affecting the cell 
viability (Figure 4.4), due to the cavitation mechanism of US-facilitated drug/gene 
delivery. Definity
®
 showed higher uptake efficiency than Optison
®
 under the same US 
conditions (e.g., 83% – 136% greater), which is consistent with some previous studies 
(Moran et al. 2000; Li et al. 2004; Miller and Dou 2004b; King et al. 2010). Sonication at 
37 ºC showed higher uptake efficiency than room temperature (e.g., ~ 50% greater in our 
study), as shown in the present and previous studies (Kim et al. 1996; Nozaki et al. 2003; 
Zarnitsyn and Prausnitz 2004).  
 We also found it important to account for the debris from lysed cells when 
determining the bioeffects caused by US. Therefore in our study, the bioeffects were 
reported as cell viability, uptake and transfection efficiency among live cells as well as 
total cells as compared to the “sham” controls. Some previous studies showed high 
uptake with high viability but this was an artifact of the analysis that did not account for 
cell debris when determining cell viability. We concluded that the literature did not show 
that it was possible to achieve high uptake with high viability by optimizing physical 
parameters. This motivated us to investigate the intracellular processes and study the 
influence of biological parameters to increased transfection efficiency. 
 US was found to be able to deliver pDNA into cell nuclei within 30 min in our 
study and other studies (Duvshani-Eshet and Machluf 2005). This could explain the rapid 
gene transfection observed within 3 ~ 4 h after US exposure (Figure 6.3), because the 
protein expression took place after about 3 h once the DNA entered the cell nucleus 
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(Mehier-Humbert et al. 2005b). Under the optimal US conditions, we found that within 
30 min after sonication, up to ~ 30% of cells had DNA uptake and most had a portion of 
the DNA already in the nuclei (Figure 6.3). Overall, ~ 30% of intracellular DNA was in 
the nuclei, ~ 30% was in the autophagosomes/autophagolysosomes and the rest was free 
in the cytoplasm (Figure 6.8). After 4 h, the percentage of cells with DNA uptake 
decreased to ~ 20% and half of those cells (i.e. ~ 10% of all cells) exhibited expression of 
the reporter protein GFP (Figure 6.3). The percentage of intracellular DNA remains at ~ 
30% in the nuclei, but increased to ~ 60% in the autophagosomes/autophagolysosomes, 
leaving just ~ 10% free in cytoplasm (Figure 6.8). The maximum transfection efficiency 
was ~ 12% at 8 h post US exposure (Figure 6.3). At later time up to 24 h, the percentage 
of cells with DNA uptake decreased continuously to ~ 10%, with most of these cells 
exhibiting GFP expression. DNA continued to be distributed ~ 30% in the nuclei and 
most or all of the rest in autophagosomes/autophagolysosomes (Figure 6.8). Further 
microarray and cell cycle analysis indicated possible cell cycle arrest in the cells with 
successful gene transfection (Figure 7.3 and 7.4) compared to the uptake cells without 
GFP expression.   
 These results suggested that the initial bioeffects caused by US exposure were 
critical to the results of gene transfection, possibly because of the cavitation mechanisms 
of US. How much of DNA that US could deliver into the cells initially, determined how 
much of DNA that could be delivered to the cell nuclei and in turn how much of gene 
transfection could be achieved later. Once the DNA got into the nuclei, it was transcribed 
and translated, but could also be lost and degraded due to cell division over time 
(Gasiorowski and Dean 2005), as we observed the decrease in uptake and transfection 
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efficiency (Figure 6.3). If this is the case, it would favor the in vivo application of US-
mediated gene transfection, because cells in tissues are generally slow in the cell cycle, so 
that once US could deliver DNA into cell nuclei, possible higher and longer transfection 
could be expected. And the US conditions that cause cell death may not induce tissue 
damage since the cells tightly packed in tissues have better tolerance to US exposure 
(Danialou et al. 2002; Li et al. 2003).  
 The microarray analysis suggested the up-regulation of GADD45α and down-
regulation of TOP2α among the cells with gene transfection compared to the uptake cells 
without GFP expression. Using drugs that regulate the expression of these two genes and 
the transport and trafficking in the cytoplasm, we found US-mediated transfection 
efficiency could be further increased. Combine US exposure and the treatment with 0.6 
mg/mL EMS and 100 µM chloroquine, or EMS alone, and we further increased 
transfection efficiency by ~ 2 fold. These results indicated that combining drug treatment 
with US exposure, we could possibly increase gene transfection efficiency as high as 
close to the DNA uptake efficiency. 
 Overall, in this study we have shown that US was able to deliver DNA to the cell 
nuclei to facilitate rapid gene transfection and by regulating intracellular processes, the 
transfection efficiency could be further increased. US has the potential to be developed as 




CHAPTER 10: FUTURE WORK 
 
Alternative Cell Lines and In Vivo Study 
 Since different cell lines may respond differently to US exposure, it is of interest 
to see whether similar regulation of intracellular processes can be found in other types of 
cells after US-mediated gene transfection, and whether the drug treatment suggested in 
this study may also increase transfection efficiency in other cell lines. Previous studies 
using other gene delivery methods have found cells undergoing mitosis were more ready 
for transfection (Wilke et al. 1996; Tseng et al. 1999). Our studies also suggested that 
cells with successful gene transfection were associated with cell cycle arrest. It is of 
interest to test whether slowing down cell cycle or preventing cells from division can 
improve US-mediated gene transfection. Although we found it difficult to synchronize 
DU145 human prostate cancer cells, it is worth investigating whether cell 
synchronization can significantly enhance gene transfection mediated by US using other 
cell lines. 
 Some of the major advantages using US as a gene delivery method include that 
US is non-invasive and easy to apply to nearly any part of the body (Rosenthal et al. 
2004), which can be reflected in the in vivo application. All the experiments in this study 
were conducted in vitro. The future work may consider transferring these in vitro results 
to in vivo studies. Some differences are expected between in vitro and in vivo studies. For 
instance, the threshold for inertial cavitation may be higher in vivo than in vitro, and 
therefore the US conditions caused damage to cell viability in vitro may not damage the 
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tightly packed cells in tissues in vivo. Different types of cells in tissues may also respond 
differently to the drug treatment tested in DU145 cells in this study. 
Quantitative Colocalization Analysis 
 Current studies on DNA trafficking mainly focused on chemical gene delivery 
systems (Colin et al. 2000; Fisher et al. 2000; Tachibana et al. 2002; Akita et al. 2004). 
There are fewer reports of DNA trafficking studies using physical delivery systems 
(Wilson et al. 1999; Golzio et al. 2002). Compared to endocytosis, the formation 
mechanism and intracellular itinerary of autophagosomes/autophagolysosomes are not 
fully clear, which may also limit the studies on DNA trafficking in physical gene delivery 
systems. The current methods for colocalization analysis of 3D images work well for 
objects of the similar size and shape but are still limited in the situation of a small object 
embedded in a large object, in which case the colocalization of DNA in the nucleus is. 
Plus, the current image analysis methods for colocalization generally provide good 
qualitative information, but not good quantitative information. The recent development of 
an imaging flow cytometer may provide a more powerful technique for quantitative 
colocalization analysis. Several papers have been published showing quantitative 
colocalization results using the ImageStream
®
 imaging flow cytometer system (Amnis, 
Seattle, WA) (Pawluczkowycz et al. 2009; Petrovas et al. 2009; Bao et al. 2010; Xu et al. 
2010). 
 It is worth noting that the Cy3/Cy5 labeling process could alter pDNA and affect 
DNA trafficking, localization, uptake and transfection (Gasiorowski and Dean 2005). For 
instance, the fluorophores were randomly attached on the plasmids with an alkylating 
aromatic nitrogen mustard (Belikova et al. 1967) and the bulky fluorophores that coat the 
 133 
plasmid may block transcription factors from binding to the DNA (Slattum et al. 2003). 
This could explain our results that transfection efficiency of unlabeled pDNA was higher 
than labeled pDNA (Figure 6.3c). An alternative peptide nucleic acid (PNA) was 
designed to specifically bind to a certain sequence of DNA and could possibly address 
this problem (Gasiorowski and Dean 2005), although further studies are required to 
evaluate whether labeling DNA with PNA is effective for microscopy imaging and 
quantitative colocalization analysis. 
 Combination of US and Other Methods to Facilitate Gene Delivery 
 In this present work, we combined US exposure with drugs that regulate 
intracellular processes and found that transfection efficiency could be further increased 
compared to the treatment with US alone. It is recommended to test the bioeffects of 
combined treatment of US with some other methods, such as chemical gene delivery 
vectors, nuclear targeting sequence and “intelligent” microbubbles. 
Combination of US Exposure and Drug Treatment 
 Only a limited number of drugs were tested in this study. There may be other 
drugs serving the same function that can possibly also enhance gene transfection. To 
better understand the influence of a particular drug on US-mediated gene transfection, a 
more variety of concentrations need to be investigated. For instance, 50 µM or less 
chloroquine was found nontoxic to cells but also ineffective, while 100 µM chloroquine 
was necessary to augment luciferase expression (Cotten et al. 1990). Similarly, the timing 
of adding these drugs (e.g., before or after US exposure) and the drug treatment time may 
also affect the results due to the different pharmaceutical kinetics. Therefore, more 
completed optimization of the concentrations and the timing of drug treatment may be 
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needed in future study. Other biological methods to regulate gene expression, such as 
siRNA, may also be tested. 
Combination of US Exposure and Other Delivery Systems 
 While naked pDNA was used in this present study, future work may consider 
selecting viral or chemical gene delivery vectors for US-mediated gene transfection. 
Several studies have reported the combination of US and adenovirus (Chen et al. 2003a), 
poly(ethylenimine) (Deshpande and Prausnitz 2007), cationic lipids (Unger et al. 1997; 
Lawrie et al. 1999; Anwer et al. 2000; Koch et al. 2000) had a synergistic effect to 
increase gene transfection. Synthetic chemical gene vectors have been found effective but 
non-biodegradable or toxic in vivo. While some biodegradable and non-toxic vectors 
were found difficult to trigger endocytosis for efficient uptake and transfection. US can 
increase the intracellular uptake and nuclear entry of these large gene delivery vectors, 
possibly alter the vector-DNA complexes and facilitate the release of DNA. On the other 
hand, these vectors may increase the stability of DNA, protect the exogenous gene from 
degrading and facilitate DNA trafficking. US exposure combined with some viral 
component may possibly achieve more stable transfection for a longer period of time. 
The combination of the advantages in various gene delivery systems may further enhance 
gene transfection compared to a single method. 
Combination of US Exposure and NLS or DTS 
 To facilitate DNA entry into the nuclei, nuclear localization signal (NLS) and 
DNA nuclear targeting sequences (DTS) have been discovered and developed. NLS is a 
variety of peptides which contains basic amino acids that can be recognized by cytosolic 
factors to mediate active transport through the nuclear pores complex on the nuclear 
 135 
envelope (Jans and Hubner 1996). It is reported that the nuclear pore complex can be 
expanded to ~30 nm during active transport (Dworetzky et al. 1988). DTS is a DNA 
sequence from the virus SV40 genome that was found to enhance nuclear import 
(Graessmann et al. 1989; Dean et al. 1999). 
 Synthetic NLS peptides have been developed to bind to DNA and facilitate DNA 
delivery into the nuclei using various gene delivery methods (Cartier and Reszka 2002). 
Several DTS were designed as an enhancer to help nuclear import in several cell lines 
(Graessmann et al. 1989; Dean 1997; Langle-Rouault et al. 1998). However, few studies 
used US as the gene delivery method. It is of interest to investigate the combination of 
US exposure with NLS or DTS, although further studies on the bioconjugation and 
behavior of the NLS-DNA or DTS-DNA complexes are required.  
US Exposure with “Intelligent” Microbubbles 
 US contrast agents can lower the threshold for cavitation and therefore enhance 
the bioeffects caused by US. The microbubble-DNA spacing, as well as microbubble-cell 
spacing and cell-DNA spacing, may have influence on transfection efficiency. Our results 
also indicated that using different contrast agents could increase US-mediated uptake 
efficiency without affecting the cell viability, and that the initial amount of DNA that US 
could deliver might be critical for the results of gene transfection, which could be 
improved by novel US contrast agents. Future studies may consider developing US 
contrast agents with multiple functions, not only as the cavitation nuclei, but also as drug 
carriers and tissue targeting for specific gene delivery purpose (Bekeredjian et al. 2006; 
Lum et al. 2006). For instance, microbubbles can be prepared to encapsulate generic 
materials and to contain ligands like antibodies or specific peptides, which would bind to 
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the specific target cells or tissues and therefore cause a close contact between 




 Overall, to make US a success for gene therapy, future research work needs to 
study the cell/tissue type dependence of the bioeffects caused by US exposure. Questions 
related to the mechanism need to be addressed, such as cavitation, DNA trafficking and 
other intracellular processes that help to facilitate gene transfection. Novel US contrast 
agents may be designed to enforce the initial bioeffects of US exposure and possibly 
enhance gene transfection by preventing DNA degradation or further improving specific 
targeting.  The regulation of intracellular processes and the advantages of other delivery 
systems may be combined with US to make it a safe and efficient tool for gene therapy. 
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APPENDIX A: CALIBRATION OF ULTRASOUND FIELD 
 
 To calibrate the input voltage to the output ultrasound pressure, the membrane 
hydrophone was located at the desired sample location. Figure A.1 shows the calibration 
curve for 1 MHz US. 
 
 
Figure A.1: Calibration of peak-to-peak pressure with the function generator 
voltage at the location of sample for US exposure.  
  























APPENDIX B: GENES DIFFERENTLY EXPRESSED IN UPTAKE 
CELLS AND TRANSFECTION CELLS 
  
 Totally 78 genes were found differentially expressed between the two groups of 
cells, 32 of which were up-regulated in transfected cells and 46 were down-regulated 
relative to cells with pDNA uptake but lacking expression (Table B.1). It is worth noting 
that there may be multiple Affymetrix probes (Affymetrix_ID) that correspond to one 
gene. 
 
Table B.1: Differentially expressed genes indentified by microarrays 
Affymetrix_ID Gene Symbol Gene Title Fold Change 
236898_at --- Transcribed locus 6.20 
1559948_at --- CDNA FLJ20447 fis, clone KAT05276 2.15 
236219_at --- --- -1.99 
212363_x_at ACTG1 actin, gamma 1 -2.55 
212738_at ARHGAP19 Rho GTPase activating protein 19 -2.81 
202672_s_at ATF3 activating transcription factor 3 2.63 
208833_s_at ATXN10 ataxin 10 -2.05 
204092_s_at AURKA aurora kinase A -2.88 
208079_s_at AURKA aurora kinase A -2.22 
1557257_at BCL10 B-cell CLL/lymphoma 10 3.29 
209642_at BUB1 
BUB1 budding uninhibited by benzimidazoles 1 
homolog (yeast) -2.93 
203755_at BUB1B 
BUB1 budding uninhibited by benzimidazoles 1 
homolog beta (yeast) -3.80 
 139 
225300_at C15orf23 chromosome 15 open reading frame 23 -2.29 
219004_s_at C21orf45 chromosome 21 open reading frame 45 -2.34 
1554314_at C6orf141 chromosome 6 open reading frame 141 2.06 
226386_at C7orf30 chromosome 7 open reading frame 30 -1.99 
213226_at CCNA2 cyclin A2 -2.39 
214710_s_at CCNB1 cyclin B1 -2.53 
201925_s_at CD55 
CD55 molecule, decay accelerating factor for 
complement (Cromer blood group) 2.66 
203213_at CDC2 cell division cycle 2, G1 to S and G2 to M -3.17 
218542_at CEP55 centrosomal protein 55kDa -2.76 
211343_s_at COL13A1 collagen, type XIII, alpha 1 -2.16 
218726_at DKFZp762E1312 hypothetical protein DKFZp762E1312 -2.13 
203764_at DLG7 discs, large homolog 7 (Drosophila) -2.33 
212573_at ENDOD1 endonuclease domain containing 1 -2.11 
1555355_a_at ETS1 
v-ets erythroblastosis virus E26 oncogene 
homolog 1 (avian) 2.51 
218980_at FHOD3 formin homology 2 domain containing 3 -2.10 




GABA(A) receptor-associated protein like 1 /// 
GABA(A) receptors associated protein like 3 4.09 
203725_at GADD45A growth arrest and DNA-damage-inducible, alpha 3.09 
210002_at GATA6 GATA binding protein 6 2.94 
219539_at GEMIN6 gem (nuclear organelle) associated protein 6 -2.12 
212959_s_at GNPTAB 
N-acetylglucosamine-1-phosphate transferase, 
alpha and beta subunits -2.00 
212906_at GRAMD1B GRAM domain containing 1B -2.49 
230031_at HSPA5 heat shock 70kDa protein 5 (glucose-regulated 2.51 
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protein, 78kDa) 
208687_x_at HSPA8 heat shock 70kDa protein 8 -3.14 
224187_x_at HSPA8 heat shock 70kDa protein 8 -2.70 
210338_s_at HSPA8 heat shock 70kDa protein 8 -2.27 
201609_x_at ICMT isoprenylcysteine carboxyl methyltransferase -2.02 
232030_at KIAA1632 KIAA1632 2.36 
218755_at KIF20A kinesin family member 20A -2.86 
209408_at KIF2C kinesin family member 2C -2.17 
1555832_s_at KLF6 Kruppel-like factor 6 2.50 
203068_at KLHL21 kelch-like 21 (Drosophila) 2.21 




karyopherin alpha 2 (RAG cohort 1, importin 
alpha 1) /// karyopherin alpha 2 (RAG cohort 1, 
importin alpha 1) /// similar to Importin alpha-2 
subunit (Karyopherin alpha-2 subunit) (SRP1-
alpha) (RAG cohort protein 1) /// similar to 
Importin alpha-2 subunit (Karyopherin alpha-2 
subunit) (SRP1-alpha) (RAG cohort protein 1) -2.82 
230298_at LOC153364 
similar to metallo-beta-lactamase superfamily 
protein -2.17 
214719_at LOC283537 hypothetical protein LOC283537 -2.50 
228089_x_at LOC374395 similar to RIKEN cDNA 1810059G22 -2.08 
227099_s_at LOC387763 hypothetical LOC387763 5.77 
242329_at LOC401317 hypothetical LOC401317 3.28 
225436_at LOC58489 hypothetical protein from EUROIMAGE 588495 -2.44 
202209_at LSM3 
LSM3 homolog, U6 small nuclear RNA 
associated (S. cerevisiae) -2.42 
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203362_s_at MAD2L1 MAD2 mitotic arrest deficient-like 1 (yeast) -2.57 
36711_at MAFF 
v-maf musculoaponeurotic fibrosarcoma 
oncogene homolog F (avian) 2.33 
203640_at MBNL2 muscleblind-like 2 (Drosophila) 2.14 
203625_x_at MCAM melanoma cell adhesion molecule -3.43 
211042_x_at MCAM 
melanoma cell adhesion molecule /// melanoma 
cell adhesion molecule -2.58 
226657_at MGC33894 transcript expressed during hematopoiesis 2 3.35 
209585_s_at MINPP1 
multiple inositol polyphosphate histidine 
phosphatase, 1 -2.52 
217980_s_at MRPL16 mitochondrial ribosomal protein L16 -2.30 
224206_x_at MYNN myoneurin 2.48 
221805_at NEFL neurofilament, light polypeptide 68kDa -2.59 
204641_at NEK2 NIMA (never in mitosis gene a)-related kinase 2 -1.98 
218014_at NUP85 nucleoporin 85kDa -2.31 
219148_at PBK PDZ binding kinase -2.34 
209382_at POLR3C 
polymerase (RNA) III (DNA directed) 
polypeptide C (62kD) 2.08 
224509_s_at RTN4IP1 
reticulon 4 interacting protein 1 /// reticulon 4 
interacting protein 1 -2.10 
202037_s_at SFRP1 secreted frizzled-related protein 1 -2.09 
230165_at SGOL2 shugoshin-like 2 (S. pombe) -2.02 
56256_at SIDT2 SID1 transmembrane family, member 2 2.17 
244070_at SYNE1 spectrin repeat containing, nuclear envelope 1 5.58 
219682_s_at TBX3 T-box 3 (ulnar mammary syndrome) 2.22 
202644_s_at TNFAIP3 tumor necrosis factor, alpha-induced protein 3 3.34 
201292_at TOP2A topoisomerase (DNA) II alpha 170kDa -4.57 
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201291_s_at TOP2A topoisomerase (DNA) II alpha 170kDa -4.26 
218145_at TRIB3 tribbles homolog 3 (Drosophila) 2.32 
210705_s_at TRIM5 tripartite motif-containing 5 2.11 
204033_at TRIP13 thyroid hormone receptor interactor 13 -2.07 
212320_at TUBB tubulin, beta -2.12 
214023_x_at TUBB2B tubulin, beta 2B 2.20 
219192_at UBAP2 ubiquitin associated protein 2 2.09 
233952_s_at ZNF295 zinc finger protein 295 2.49 
219228_at ZNF331 zinc finger protein 331 2.99 
1554248_at ZNF638 zinc finger protein 638 3.63 




APPENDIX C: DNA ELECTROPHORESIS 
 
DNA electrophoresis was carried out after qRT-PCR to confirm the expression of 
the two genes of interest: TOP2α and GADD45α (Figure C.1).  
 
Figure C.1: DNA electrophoresis after qRT-PCR. The upper image shows the expression 
of TOP2α and GADD45α in the cells with DNA uptake but no transfection. The bottom 
image shows that in the cells with gene transfection. 
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APPENDIX D: CELL VIABILITY WITH DRUG TREATMENT 
 
Cell viability after US exposure was not affected by EMS, chloroquine, tetracaine, 
but decreased with the treatment of NMDA, PRIMA-1, amsacrine, etoposide, 




Figure D.1: The fold change of cell viability with drug treatment compared to that 
without drug treatment. Data represent the averages of n ≥ 3 replicates. The error 
bars represent 95% confidence interval (*Student’s t-test p < 0.05, compared to no 
drug treatment). The concentration used for each drug: 0.6 mg/mL EMS, 2 mM 
NMDA, 1 mM PRIMA-1, 200 nM amsacrine, 100 µM chloroquine, 200 nM 
etoposide, 200 nM mitoxantrone, 50 nM aclarubicin, 16 µM paclitaxel, 16 µM 
docetaxel, 20 µM tetracaine and 250 nM bafilomycin A1. US conditions: pressure 
amplitude of 0.78 MPa, total treatment time of 1 min with a pulse length of 0.25 ms 
at a duty cycle of 25%, Definity
®
 concentration of 1 vol%. 
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